Recombinant	O
NFAT1	B-protein
(	O
NFATp	O
)	O
is	O
regulated	O
by	O
calcineurin	O
in	O
T	B-cell_type
cells	I-cell_type
and	O
mediates	O
transcription	O
of	O
several	O
cytokine	B-DNA
genes	I-DNA
.	O

Transcription	B-protein
factors	I-protein
of	O
the	O
NFAT	B-protein
family	I-protein
play	O
a	O
key	O
role	O
in	O
the	O
transcription	O
of	O
cytokine	B-DNA
genes	I-DNA
and	O
other	O
genes	O
during	O
the	O
immune	O
response	O
.	O

We	O
have	O
identified	O
two	O
new	O
isoforms	O
of	O
the	O
transcription	B-protein
factor	I-protein
NFAT1	B-protein
(	O
previously	O
termed	O
NFATp	B-protein
)	O
that	O
are	O
the	O
predominant	O
isoforms	O
expressed	O
in	O
murine	B-cell_type
and	I-cell_type
human	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

When	O
expressed	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
,	O
recombinant	O
NFAT1	B-protein
is	O
regulated	O
,	O
as	O
expected	O
,	O
by	O
the	O
calmodulin-dependent	B-protein
phosphatase	I-protein
calcineurin	B-protein
,	O
and	O
its	O
function	O
is	O
inhibited	O
by	O
the	O
immunosuppressive	O
agent	O
cyclosporin	O
A	O
(	O
CsA	O
)	O
.	O

Transactivation	O
by	O
recombinant	O
NFAT1	B-protein
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
requires	O
dual	O
stimulation	O
with	O
ionomycin	O
and	O
phorbol	O
12-myristate	O
13-acetate	O
;	O
this	O
activity	O
is	O
potentiated	O
by	O
coexpression	O
of	O
constitutively	O
active	O
calcineurin	B-protein
and	O
is	O
inhibited	O
by	O
CsA	O
.	O

Immunocytochemical	O
analysis	O
indicates	O
that	O
recombinant	O
NFAT1	B-protein
localizes	O
in	O
the	O
cytoplasm	O
of	O
transiently	B-cell_type
transfected	I-cell_type
T	I-cell_type
cells	I-cell_type
and	O
translocates	O
into	O
the	O
nucleus	O
in	O
a	O
CsA-sensitive	O
manner	O
following	O
ionomycin	O
stimulation	O
.	O

When	O
expressed	O
in	O
COS	B-cell_line
cells	I-cell_line
,	O
however	O
,	O
NFAT1	B-protein
is	O
capable	O
of	O
transactivation	O
,	O
but	O
it	O
is	O
not	O
regulated	O
correctly	O
:	O
its	O
subcellular	O
localization	O
and	O
transcriptional	O
function	O
are	O
not	O
affected	O
by	O
stimulation	O
of	O
the	O
COS	B-cell_line
cells	I-cell_line
with	O
ionomycin	O
and	O
phorbol	O
12-myristate	O
13-acetate	O
.	O

Recombinant	O
NFAT1	B-protein
can	O
mediate	O
transcription	O
of	O
the	O
interleukin-2	B-protein
,	O
interleukin-4	O
,	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
,	O
and	O
granulocyte-macrophage	B-DNA
colony-stimulating	I-DNA
factor	I-DNA
promoters	I-DNA
in	O
T	B-cell_type
cells	I-cell_type
,	O
suggesting	O
that	O
NFAT1	B-protein
contributes	O
to	O
the	O
CsA-sensitive	O
transcription	O
of	O
these	O
genes	B-DNA
during	O
the	O
immune	O
response	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
July	NULL
1996	NULL
,	NULL
p.	NULL
3955-3966	NULL
0270-7306/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

16	NULL
,	NULL
No	NULL
.	NULL

7	NULL
Recombinant	NULL
NFAT1	NULL
(	NULL
NFATp	NULL
)	NULL
Is	NULL
Regulated	NULL
by	NULL
Calcineurin	NULL
in	NULL
T	NULL
Cells	NULL
and	NULL
Mediates	NULL
Transcription	NULL
of	NULL
Several	NULL
Cytokine	NULL
Genes	NULL
CHUN	NULL
LUO	NULL
,	NULL
*	NULL
EMMANUEL	NULL
BURGEON	NULL
,	NULL
*	NULL
JOSEPHINE	NULL
A.	NULL
CAREW	NULL
,	NULL
*	NULL
``	NULL
PATRICIA	NULL
G.	NULL
McCAFFREY	NULL
,	NULL
``	NULL
¢	NULL
TINA	NULL
M.	NULL
BADALIAN	NULL
,	NULL
**	NULL
WILLIAM	NULL
S.	NULL
LANE	NULL
,	NULL
*	NULL
PATRICK	NULL
G.	NULL
HOGAN	NULL
,	NULL
``	NULL
anp	NULL
ANJANA	NULL
RAO®*	NULL
Division	NULL
of	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Pathology	NULL
and	NULL
Department	NULL
of	NULL
Neurobiology	NULL
,	NULL
``	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
,	NULL
and	NULL
Microchemistry	NULL
Facility	NULL
,	NULL
Harvard	NULL
University	NULL
,	NULL
Cambridge	NULL
,	NULL
Massachusetts	NULL
02138*	NULL
Received	NULL
18	NULL
December	NULL
1995/Returned	NULL
for	NULL
modification	NULL
1	NULL
February	NULL
1996/Accepted	NULL
9	NULL
April	NULL
1996	NULL
Transcription	NULL
factors	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
cytokine	NULL
genes	NULL
and	NULL
other	NULL
genes	NULL
during	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
two	NULL
new	NULL
isoforms	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
(	NULL
previously	NULL
termed	NULL
NFATp	NULL
)	NULL
that	NULL
are	NULL
the	NULL
predominant	NULL
isoforms	NULL
expressed	NULL
in	NULL
murine	NULL
and	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

When	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
recombinant	NULL
NFAT1	NULL
is	NULL
regulated	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
by	NULL
the	NULL
calmodulin-dependent	NULL
phosphatase	NULL
calcineurin	NULL
,	NULL
and	NULL
its	NULL
function	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
immunosuppressive	NULL
agent	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
.	NULL

Transactivation	NULL
by	NULL
recombinant	NULL
NFAT1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
requires	NULL
dual	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
and	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
this	NULL
activity	NULL
is	NULL
potentiated	NULL
by	NULL
coexpression	NULL
of	NULL
constitutively	NULL
active	NULL
calcineurin	NULL
and	NULL
is	NULL
inhibited	NULL
by	NULL
CsA	NULL
.	NULL

Immunocytochemical	NULL
analysis	NULL
indicates	NULL
that	NULL
recombinant	NULL
NFAT1	NULL
localizes	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
transiently	NULL
transfected	NULL
T	NULL
cells	NULL
and	NULL
translocates	NULL
into	NULL
the	NULL
nucleus	NULL
in	NULL
a	NULL
CsA-sensitive	NULL
manner	NULL
following	NULL
ionomycin	NULL
stimulation	NULL
.	NULL

When	NULL
expressed	NULL
in	NULL
COS	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
NFAT1	NULL
is	NULL
capable	NULL
of	NULL
transactivation	NULL
,	NULL
but	NULL
it	NULL
is	NULL
not	NULL
regulated	NULL
correctly	NULL
:	NULL
its	NULL
subcellular	NULL
localization	NULL
and	NULL
transcriptional	NULL
function	NULL
are	NULL
not	NULL
affected	NULL
by	NULL
stimulation	NULL
of	NULL
the	NULL
COS	NULL
cells	NULL
with	NULL
ionomycin	NULL
and	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
.	NULL

Recombinant	NULL
NFAT1	NULL
can	NULL
mediate	NULL
transcription	NULL
of	NULL
the	NULL
interleukin-2	NULL
,	NULL
interleukin-4	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoters	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
NFAT1	NULL
contributes	NULL
to	NULL
the	NULL
CsA-sensitive	NULL
transcription	NULL
of	NULL
these	NULL
genes	NULL
during	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

The	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
was	NULL
originally	NULL
identified	NULL
in	NULL
T	NULL
cells	NULL
as	NULL
an	NULL
essential	NULL
transcription	NULL
factor	NULL
for	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
gene	NULL
expression	NULL
(	NULL
54	NULL
)	NULL
.	NULL

NFAT	NULL
DNA-binding	NULL
activity	NULL
has	NULL
since	NULL
been	NULL
detected	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
mast	NULL
cells	NULL
,	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
19	NULL
,	NULL
46	NULL
,	NULL
63	NULL
,	NULL
67	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
binding	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
NFAT	NULL
binds	NULL
to	NULL
sites	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
several	NULL
other	NULL
cytokine	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
genes	NULL
encoding	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
(	NULL
14	NULL
,	NULL
31	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
6	NULL
,	NULL
49	NULL
,	NULL
58	NULL
)	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
(	NULL
8	NULL
,	NULL
24	NULL
,	NULL
29	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
have	NULL
suggested	NULL
that	NULL
NFAT	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
coordinating	NULL
cytokine	NULL
gene	NULL
transcription	NULL
during	NULL
the	NULL
immune	NULL
response	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
47	NULL
)	NULL
.	NULL

A	NULL
component	NULL
of	NULL
the	NULL
NFAT	NULL
complex	NULL
is	NULL
present	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
and	NULL
can	NULL
be	NULL
detected	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
autonomously	NULL
to	NULL
certain	NULL
NFAT	NULL
sites	NULL
(	NULL
23	NULL
,	NULL
33	NULL
,	NULL
48	NULL
)	NULL
.	NULL

This	NULL
component	NULL
(	NULL
NFATp	NULL
or	NULL
NFATe	NULL
)	NULL
appears	NULL
in	NULL
the	NULL
nucleus	NULL
following	NULL
stimulation	NULL
with	NULL
T-cell	NULL
receptor	NULL
ligands	NULL
,	NULL
calcium	NULL
ionophores	NULL
,	NULL
or	NULL
other	NULL
agents	NULL
that	NULL
induce	NULL
an	NULL
increase	NULL
in	NULL
cytoplasmic	NULL
free	NULL
cal-cium	NULL
,	NULL
and	NULL
it	NULL
confers	NULL
the	NULL
DNA-binding	NULL
specificity	NULL
of	NULL
NFAT	NULL
(	NULL
33	NULL
)	NULL
.	NULL

However	NULL
,	NULL
full	NULL
transactivation	NULL
by	NULL
NFAT	NULL
requires	NULL
the	NULL
participation	NULL
of	NULL
a	NULL
nuclear	NULL
component	NULL
that	NULL
is	NULL
synthesized	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
with	NULL
phorbol	NULL
esters	NULL
such	NULL
as	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
(	NULL
11	NULL
)	NULL
and	NULL
includes	NULL
members	NULL
of	NULL
the	NULL
AP-1	NULL
(	NULL
Fos/Jun	NULL
)	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
2	NULL
,	NULL
22	NULL
,	NULL
42	NULL
,	NULL
49	NULL
)	NULL
.	NULL

AP-1	NULL
proteins	NULL
bind	NULL
cooperatively	NULL
with	NULL
NFAT	NULL
to	NULL
NFAT	NULL
sites	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Present	NULL
address	NULL
:	NULL
Center	NULL
for	NULL
Blood	NULL
Re-search	NULL
,	NULL
Warren	NULL
Alpert	NULL
Bldg	NULL
.	NULL

,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
200	NULL
Longwood	NULL
Ave.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
617	NULL
)	NULL
278-3260	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
617	NULL
)	NULL
278-3280	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
arao	NULL
@	NULL
cbr.med.harvard.edu	NULL
.	NULL

¢	NULL
Present	NULL
address	NULL
:	NULL
Vertex	NULL
Pharmaceuticals	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
02139	NULL
.	NULL

3955	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
cytokine	NULL
genes	NULL
and	NULL
stabilize	NULL
the	NULL
NFAT	NULL
complex	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Calcium	NULL
ionophores	NULL
such	NULL
as	NULL
ionomycin	NULL
,	NULL
together	NULL
with	NULL
PMA	NULL
,	NULL
mimic	NULL
stimulation	NULL
through	NULL
the	NULL
T-cell	NULL
re-ceptor	NULL
,	NULL
inducing	NULL
cytokine	NULL
gene	NULL
expression	NULL
and	NULL
activating	NULL
transcription	NULL
of	NULL
reporter	NULL
genes	NULL
controlled	NULL
by	NULL
NFAT	NULL
sites	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cytokine	NULL
genes	NULL
(	NULL
30	NULL
,	NULL
65	NULL
)	NULL
.	NULL

A	NULL
central	NULL
aspect	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
is	NULL
that	NULL
the	NULL
appearance	NULL
of	NULL
NFAT	NULL
DNA-binding	NULL
activity	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
is	NULL
blocked	NULL
by	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
and	NULL
FK506	NULL
(	NULL
3	NULL
,	NULL
30	NULL
)	NULL
.	NULL

CsA	NULL
and	NULL
FK506	NULL
form	NULL
complexes	NULL
with	NULL
their	NULL
intracellular	NULL
receptors	NULL
(	NULL
immunophilins	NULL
)	NULL
,	NULL
and	NULL
the	NULL
drug-immunophilin	NULL
complexes	NULL
inhibit	NULL
the	NULL
phosphatase	NULL
activity	NULL
of	NULL
calcineurin	NULL
(	NULL
protein	NULL
phosphatase	NULL
2B	NULL
)	NULL
,	NULL
a	NULL
ubiquitous	NULL
calcium-	NULL
and	NULL
calmodulin-dependent	NULL
phosphatase	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
26	NULL
)	NULL
.	NULL

CsA	NULL
and	NULL
FK506	NULL
inhibit	NULL
the	NULL
transcription	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
(	NULL
60	NULL
)	NULL
,	NULL
at	NULL
least	NULL
partly	NULL
by	NULL
inhibiting	NULL
the	NULL
calcineurin-dependent	NULL
translocation	NULL
of	NULL
the	NULL
preexisting	NULL
subunit	NULL
of	NULL
NFAT	NULL
to	NULL
the	NULL
nucleus	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
wild-type	NULL
calcineurin	NULL
or	NULL
a	NULL
constitutively	NULL
active	NULL
form	NULL
of	NULL
calcineurin	NULL
substitutes	NULL
for	NULL
the	NULL
calcium	NULL
requirement	NULL
in	NULL
T-cell	NULL
stimulation	NULL
and	NULL
reduces	NULL
the	NULL
sensitivity	NULL
of	NULL
gene	NULL
expression	NULL
to	NULL
inhibition	NULL
by	NULL
CsA	NULL
and	NULL
FK506	NULL
(	NULL
7	NULL
,	NULL
15	NULL
,	NULL
25	NULL
,	NULL
43	NULL
,	NULL
62	NULL
,	NULL
65	NULL
)	NULL
.	NULL

The	NULL
hunt	NULL
for	NULL
the	NULL
NFATp/c	NULL
component	NULL
of	NULL
NFAT	NULL
led	NULL
to	NULL
the	NULL
isolation	NULL
of	NULL
cDNAs	NULL
encoding	NULL
four	NULL
distinct	NULL
classes	NULL
of	NULL
proteins	NULL
:	NULL
NFATp	NULL
,	NULL
NFATc	NULL
,	NULL
NFAT3	NULL
,	NULL
and	NULL
NFATx-NFAT4-NFATc3	NULL
(	NULL
NFATxz/4/c3	NULL
)	NULL
(	NULL
17	NULL
,	NULL
18	NULL
,	NULL
28	NULL
,	NULL
32	NULL
,	NULL
41	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
define	NULL
a	NULL
novel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
whose	NULL
conserved	NULL
DNA-binding	NULL
domains	NULL
show	NULL
a	NULL
weak	NULL
similarity	NULL
to	NULL
the	NULL
DNA-binding	NULL
domains	NULL
of	NULL
Rel	NULL
family	NULL
proteins	NULL
(	NULL
18	NULL
,	NULL
20	NULL
,	NULL
40	NULL
)	NULL
.	NULL

The	NULL
DNA-binding	NULL
domains	NULL
of	NULL
all	NULL
four	NULL
NFAT	NULL
family	NULL
proteins	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
cooperatively	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
proteins	NULL
at	NULL
the	NULL
IL-2	NULL
promoter	NULL
NFAT	NULL
site	NULL
(	NULL
18	NULL
,	NULL
20	NULL
,	NULL
28	NULL
)	NULL
.	NULL

The	NULL
mRNAs	NULL
encoding	NULL
all	NULL
3956	NULL
LUO	NULL
ET	NULL
AL	NULL
.	NULL

four	NULL
proteins	NULL
are	NULL
detected	NULL
in	NULL
human	NULL
lymphocytes	NULL
but	NULL
differ	NULL
in	NULL
their	NULL
patterns	NULL
of	NULL
expression	NULL
in	NULL
other	NULL
cells	NULL
and	NULL
tissues	NULL
and	NULL
in	NULL
their	NULL
representation	NULL
in	NULL
resting	NULL
and	NULL
activated	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
28	NULL
,	NULL
41	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
each	NULL
protein	NULL
may	NULL
subserve	NULL
specific	NULL
functions	NULL
.	NULL

The	NULL
individual	NULL
roles	NULL
of	NULL
NFAT	NULL
family	NULL
proteins	NULL
in	NULL
regulating	NULL
gene	NULL
expression	NULL
in	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
remain	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

The	NULL
terms	NULL
NFATp	NULL
and	NULL
NFATc	NULL
were	NULL
originally	NULL
used	NULL
to	NULL
describe	NULL
DNA-binding	NULL
activities	NULL
present	NULL
in	NULL
cellular	NULL
extracts	NULL
;	NULL
hence	NULL
,	NULL
more	NULL
than	NULL
one	NULL
NFAT	NULL
family	NULL
protein	NULL
may	NULL
have	NULL
been	NULL
present	NULL
in	NULL
the	NULL
original	NULL
NFATp	NULL
(	NULL
preexisting	NULL
)	NULL
and	NULL
NFATe	NULL
(	NULL
cytoplasmic	NULL
)	NULL
preparations	NULL
(	NULL
11	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
nomenclature	NULL
used	NULL
by	NULL
Hoey	NULL
et	NULL
al	NULL
.	NULL

(	NULL
18	NULL
)	NULL
,	NULL
here	NULL
we	NULL
rename	NULL
NFATp	NULL
,	NULL
the	NULL
first	NULL
isolated	NULL
NFAT	NULL
family	NULL
member	NULL
(	NULL
32	NULL
)	NULL
,	NULL
as	NULL
NFAT1	NULL
.	NULL

We	NULL
use	NULL
this	NULL
nomenclature	NULL
since	NULL
it	NULL
makes	NULL
no	NULL
assumptions	NULL
about	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
this	NULL
protein	NULL
or	NULL
its	NULL
level	NULL
of	NULL
expression	NULL
in	NULL
resting	NULL
cells	NULL
.	NULL

We	NULL
report	NULL
here	NULL
the	NULL
cloning	NULL
of	NULL
two	NULL
new	NULL
isoforms	NULL
of	NULL
NFAT1	NULL
that	NULL
are	NULL
the	NULL
predominant	NULL
isoforms	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
subcellular	NULL
localization	NULL
and	NULL
transactivation	NULL
functions	NULL
of	NULL
recombinant	NULL
NFAT1	NULL
are	NULL
regulated	NULL
by	NULL
calcineurin	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
expected	NULL
for	NULL
the	NULL
preexisting	NULL
,	NULL
cytoplasmic	NULL
component	NULL
of	NULL
NFAT	NULL
(	NULL
7	NULL
,	NULL
26	NULL
,	NULL
47	NULL
)	NULL
and	NULL
as	NULL
previously	NULL
shown	NULL
for	NULL
endogenous	NULL
murine	NULL
NFAT1	NULL
(	NULL
51	NULL
,	NULL
55	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
recombinant	NULL
NFAT1	NULL
behaves	NULL
aberrantly	NULL
in	NULL
COS	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
NFAT1	NULL
is	NULL
not	NULL
regulated	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
.	NULL

We	NULL
show	NULL
that	NULL
recombinant	NULL
NFAT1	NULL
mediates	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
GM-CSF	NULL
promoters	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
NFAT1	NULL
participates	NULL
in	NULL
the	NULL
CsA-sensitive	NULL
transcription	NULL
of	NULL
these	NULL
cytokine	NULL
genes	NULL
during	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Library	NULL
screening	NULL
and	NULL
sequence	NULL
analysis	NULL
.	NULL

The	NULL
cloning	NULL
strategy	NULL
for	NULL
murine	NULL
NFAT1	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

Isolation	NULL
of	NULL
clone	NULL
Q1B1	NULL
from	NULL
a	NULL
murine	NULL
Ar-5	NULL
T-cell	NULL
AZAPII	NULL
cDNA	NULL
library	NULL
with	NULL
probe	NULL
a	NULL
has	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Probe	NULL
b	NULL
,	NULL
a	NULL
573-bp	NULL
EcoRI	NULL
(	NULL
5	NULL
'	NULL
site	NULL
in	NULL
the	NULL
polylinker	NULL
of	NULL
pBluescript	NULL
)	NULL
fragment	NULL
corresponding	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
clone	NULL
Q1B1	NULL
,	NULL
was	NULL
used	NULL
to	NULL
screen	NULL
the	NULL
cDNA	NULL
library	NULL
and	NULL
an	NULL
amplified	NULL
murine	NULL
\	NULL
129	NULL
SV	NULL
genomic	NULL
library	NULL
(	NULL
Stratagene	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
32	NULL
)	NULL
.	NULL

A	NULL
genomic	NULL
fragment	NULL
hybridizing	NULL
with	NULL
the	NULL
probe	NULL
was	NULL
sequenced	NULL
and	NULL
found	NULL
to	NULL
encode	NULL
two	NULL
tryptic	NULL
peptides	NULL
of	NULL
purified	NULL
murine	NULL
NFAT1	NULL
,	NULL
which	NULL
were	NULL
not	NULL
found	NULL
in	NULL
the	NULL
original	NULL
partial	NULL
cDNA	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

A	NULL
300-bp	NULL
Pvul-Bg/I	NULL
probe	NULL
(	NULL
probe	NULL
c	NULL
)	NULL
from	NULL
this	NULL
genomic	NULL
fragment	NULL
was	NULL
used	NULL
to	NULL
isolate	NULL
four	NULL
clones	NULL
corresponding	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
NFAT1	NULL
cDNA	NULL
.	NULL

All	NULL
of	NULL
the	NULL
5°	NULL
cDNA	NULL
clones	NULL
overlap	NULL
the	NULL
original	NULL
partial	NULL
cDNA	NULL
sequence	NULL
,	NULL
but	NULL
none	NULL
of	NULL
the	NULL
isolated	NULL
clones	NULL
spans	NULL
the	NULL
full	NULL
coding	NULL
sequence	NULL
.	NULL

Several	NULL
of	NULL
the	NULL
3	NULL
'	NULL
cDNA	NULL
clones	NULL
have	NULL
long	NULL
3	NULL
'	NULL
untranslated	NULL
sequences	NULL
,	NULL
but	NULL
none	NULL
contains	NULL
a	NULL
polyadenylation	NULL
site	NULL
or	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tail	NULL
.	NULL

This	NULL
is	NULL
not	NULL
surprising	NULL
,	NULL
since	NULL
the	NULL
mRNA	NULL
of	NULL
NFAT1	NULL
is	NULL
~8	NULL
kb	NULL
long	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
clones	NULL
were	NULL
excised	NULL
into	NULL
pBluescript	NULL
SK	NULL
(	NULL
-	NULL
)	NULL
as	NULL
instructed	NULL
by	NULL
the	NULL
supplier	NULL
,	NULL
and	NULL
the	NULL
inserts	NULL
were	NULL
aligned	NULL
by	NULL
restriction	NULL
mapping	NULL
.	NULL

Both	NULL
strands	NULL
of	NULL
several	NULL
cDNA	NULL
and	NULL
genomic	NULL
clones	NULL
spanning	NULL
the	NULL
full	NULL
coding	NULL
sequence	NULL
of	NULL
NFAT1	NULL
were	NULL
sequenced	NULL
with	NULL
a	NULL
Sequenase	NULL
kit	NULL
(	NULL
U.S.	NULL
Biochemical	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
of	NULL
clone	NULL
Q1B1	NULL
was	NULL
removed	NULL
by	NULL
excising	NULL
the	NULL
fragment	NULL
between	NULL
the	NULL
AvrlI	NULL
site	NULL
in	NULL
the	NULL
cDNA	NULL
(	NULL
3	NULL
'	NULL
of	NULL
the	NULL
stop	NULL
codon	NULL
)	NULL
and	NULL
the	NULL
EcoRV	NULL
site	NULL
in	NULL
the	NULL
polylinker	NULL
of	NULL
pBluescript	NULL
.	NULL

The	NULL
full-length	NULL
cDNA	NULL
was	NULL
constructed	NULL
by	NULL
replacing	NULL
the	NULL
NofT	NULL
(	NULL
in	NULL
pBluescript	NULL
)	NULL
-to-Bsm1I	NULL
fragment	NULL
of	NULL
this	NULL
plasmid	NULL
with	NULL
the	NULL
NofI-Bsml	NULL
fragment	NULL
of	NULL
an	NULL
overlapping	NULL
5	NULL
'	NULL
clone	NULL
(	NULL
U1	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
pNFAT1-A	NULL
,	NULL
which	NULL
has	NULL
the	NULL
full-length	NULL
coding	NULL
sequence	NULL
for	NULL
the	NULL
murine	NULL
NFAT1-A	NULL
with	NULL
54-bp	NULL
5	NULL
'	NULL
and	NULL
154-bp	NULL
3	NULL
'	NULL
untranslated	NULL
regions	NULL
.	NULL

The	NULL
cloning	NULL
strategy	NULL
for	NULL
human	NULL
NFAT1	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

Probe	NULL
b	NULL
was	NULL
used	NULL
to	NULL
screen	NULL
a	NULL
Jurkat	NULL
cDNA	NULL
library	NULL
,	NULL
and	NULL
one	NULL
clone	NULL
(	NULL
21B2	NULL
)	NULL
with	NULL
1,466	NULL
bp	NULL
of	NULL
human	NULL
NFAT1	NULL
cDNA	NULL
was	NULL
isolated	NULL
.	NULL

Comparison	NULL
with	NULL
murine	NULL
cDNA	NULL
clones	NULL
indicated	NULL
that	NULL
this	NULL
human	NULL
clone	NULL
corresponds	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
NFAT1	NULL
cDNA	NULL
.	NULL

The	NULL
same	NULL
cDNA	NULL
library	NULL
was	NULL
screened	NULL
again	NULL
with	NULL
probe	NULL
d	NULL
(	NULL
736	NULL
bp	NULL
;	NULL
NheT	NULL
site	NULL
to	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
21B2	NULL
)	NULL
,	NULL
and	NULL
several	NULL
overlapping	NULL
clones	NULL
which	NULL
span	NULL
the	NULL
region	NULL
between	NULL
nucle-otides	NULL
997	NULL
and	NULL
2229	NULL
of	NULL
the	NULL
human	NULL
cDNA	NULL
were	NULL
isolated	NULL
.	NULL

Rescreening	NULL
with	NULL
probe	NULL
e	NULL
(	NULL
629	NULL
bp	NULL
;	NULL
Beill	NULL
site	NULL
to	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
clone	NULL
42	NULL
)	NULL
isolated	NULL
additional	NULL
clones	NULL
,	NULL
most	NULL
(	NULL
five	NULL
of	NULL
seven	NULL
)	NULL
of	NULL
which	NULL
ended	NULL
close	NULL
to	NULL
the	NULL
end	NULL
of	NULL
the	NULL
Rel	NULL
similarity	NULL
region	NULL
.	NULL

However	NULL
,	NULL
one	NULL
clone	NULL
(	NULL
118A	NULL
)	NULL
appeared	NULL
to	NULL
be	NULL
a	NULL
shorter	NULL
variant	NULL
with	NULL
a	NULL
3	NULL
'	NULL
region	NULL
similar	NULL
to	NULL
the	NULL
3	NULL
'	NULL
terminus	NULL
of	NULL
murine	NULL
NFAT1-C	NULL
,	NULL
while	NULL
another	NULL
(	NULL
103A	NULL
)	NULL
contained	NULL
sequence	NULL
corresponding	NULL
to	NULL
the	NULL
murine	NULL
isoform	NULL
C.	NULL
Sequence	NULL
analysis	NULL
was	NULL
done	NULL
with	NULL
the	NULL
GCG	NULL
program	NULL
package	NULL
(	NULL
Genetics	NULL
Computer	NULL
Group	NULL
,	NULL
Inc	NULL
)	NULL
.	NULL

RT-PCR	NULL
.	NULL

Cytosolic	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Primers	NULL
(	NULL
1	NULL
,	NULL
5'-AAGAGCCAGCCCAACATGC-3	NULL
'	NULL
;	NULL
2	NULL
,	NULL
5-CAGCCTTACTACCCCCAGCAC-3	NULL
'	NULL
;	NULL
3	NULL
,	NULL
5	NULL
``	NULL
-CGCTCTAGAAGGAGGTCCTG	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

AAAACT-3	NULL
'	NULL
;	NULL
and	NULL
4	NULL
,	NULL
added	NULL
restriction	NULL
enzyme	NULL
sites	NULL
are	NULL
underlined	NULL
)	NULL
were	NULL
synthesized	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
sequence	NULL
of	NULL
clone	NULL
103A	NULL
.	NULL

Primers	NULL
3	NULL
and	NULL
4	NULL
were	NULL
used	NULL
to	NULL
make	NULL
cDNA	NULL
from	NULL
Jurkat	NULL
cytosolic	NULL
RNA	NULL
;	NULL
the	NULL
cDNA	NULL
made	NULL
was	NULL
used	NULL
as	NULL
the	NULL
template	NULL
for	NULL
PCR	NULL
with	NULL
primer	NULL
3	NULL
as	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
and	NULL
primer	NULL
1	NULL
or	NULL
2	NULL
as	NULL
the	NULL
5	NULL
'	NULL
primer	NULL
,	NULL
using	NULL
a	NULL
SuperScript	NULL
reverse	NULL
transcription-PCR	NULL
(	NULL
RT-PCR	NULL
)	NULL
kit	NULL
(	NULL
Life	NULL
Technology	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
B-	NULL
and	NULL
C-like	NULL
PCR	NULL
products	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
were	NULL
subcloned	NULL
into	NULL
plasmid	NULL
pBluescript	NULL
KS	NULL
(	NULL
-	NULL
)	NULL
and	NULL
sequenced	NULL
.	NULL

Plasmids	NULL
.	NULL

Expression	NULL
plasmids	NULL
encoding	NULL
full-length	NULL
murine	NULL
NFAT1	NULL
isoforms	NULL
were	NULL
constructed	NULL
by	NULL
using	NULL
plasmid	NULL
pLGP3	NULL
(	NULL
39	NULL
)	NULL
.	NULL

An	NULL
intermediate	NULL
plasmid	NULL
was	NULL
made	NULL
by	NULL
subcloning	NULL
the	NULL
EcoRI-Avrll	NULL
fragment	NULL
of	NULL
the	NULL
partial	NULL
murine	NULL
NFAT1-A	NULL
cDNA	NULL
(	NULL
32	NULL
)	NULL
into	NULL
pLGP3	NULL
.	NULL

To	NULL
generate	NULL
the	NULL
C	NULL
termini	NULL
for	NULL
the	NULL
B	NULL
and	NULL
C	NULL
isoforms	NULL
,	NULL
PCR	NULL
products	NULL
were	NULL
made	NULL
by	NULL
using	NULL
Taq	NULL
polymerase	NULL
(	NULL
Perkin-Elmer	NULL
)	NULL
and	NULL
the	NULL
corresponding	NULL
cDNA	NULL
clones	NULL
as	NULL
templates	NULL
.	NULL

The	NULL
common	NULL
5	NULL
'	NULL
primer	NULL
used	NULL
was	NULL
5'-CT	NULL
GAGCCCGGGCGC-3	NULL
'	NULL
,	NULL
and	NULL
the	NULL
specific	NULL
3	NULL
'	NULL
primers	NULL
were	NULL
5'-CGACGGAAGCT	NULL
TGATCAAAGACCAGTCAC-3	NULL
'	NULL
for	NULL
isoform	NULL
B	NULL
and	NULL
5'-CGACGGAAGCTTGC	NULL
GTCGCGAGATTATGT-3	NULL
'	NULL
for	NULL
isoform	NULL
C.	NULL
The	NULL
3	NULL
'	NULL
primers	NULL
have	NULL
a	NULL
HindIII	NULL
site	NULL
(	NULL
underlined	NULL
)	NULL
introduced	NULL
for	NULL
cloning	NULL
.	NULL

The	NULL
SmeI-HindIII	NULL
fragment	NULL
of	NULL
the	NULL
intermediate	NULL
plasmid	NULL
was	NULL
replaced	NULL
by	NULL
the	NULL
SmaI-HindIII	NULL
fragments	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
encoding	NULL
the	NULL
C	NULL
termini	NULL
of	NULL
the	NULL
B	NULL
and	NULL
C	NULL
isoforms	NULL
,	NULL
resulting	NULL
in	NULL
intermediate	NULL
plasmids	NULL
for	NULL
isoform	NULL
B	NULL
and	NULL
C.	NULL
Plasmids	NULL
pLGPmNFAT1-A	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-C	NULL
were	NULL
constructed	NULL
by	NULL
subcloning	NULL
the	NULL
Spel	NULL
(	NULL
polylinker	NULL
)	NULL
-Bg/lI	NULL
fragment	NULL
of	NULL
pNFAT1-A	NULL
into	NULL
these	NULL
intermediate	NULL
plasmids	NULL
between	NULL
the	NULL
EcoRI	NULL
(	NULL
polylinker	NULL
of	NULL
pLGP3	NULL
)	NULL
and	NULL
Bg/lI	NULL
sites	NULL
.	NULL

A	NULL
derivative	NULL
of	NULL
pEFBOS	NULL
(	NULL
36	NULL
)	NULL
,	NULL
plasmid	NULL
pEFBOSCX	NULL
,	NULL
which	NULL
has	NULL
the	NULL
Xbel-Xbal	NULL
stuffer	NULL
fragment	NULL
replaced	NULL
by	NULL
a	NULL
polylinker	NULL
with	NULL
Cll	NULL
,	NULL
Sefl	NULL
,	NULL
BamHI	NULL
,	NULL
and	NULL
Xbel	NULL
sites	NULL
,	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
D.	NULL
A.	NULL
Cantrell	NULL
,	NULL
and	NULL
pACTAG2	NULL
(	NULL
59	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
M.	NULL
Tremblay	NULL
.	NULL

The	NULL
HindIII-Xbal	NULL
fragment	NULL
encoding	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
hemagglutinin	NULL
(	NULL
HA	NULL
)	NULL
epitope	NULL
tag	NULL
(	NULL
YPYDVPDYA	NULL
)	NULL
from	NULL
pACTAG2	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
Seil	NULL
and	NULL
Xbal	NULL
sites	NULL
of	NULL
pEFBOSCX	NULL
,	NULL
resulting	NULL
in	NULL
pEFTAG	NULL
.	NULL

The	NULL
AatlI-HindIII	NULL
fragments	NULL
of	NULL
NFAT1-A	NULL
,	NULL
NFAT1-B	NULL
,	NULL
and	NULL
NFAT1-C	NULL
from	NULL
the	NULL
pLGP3	NULL
expression	NULL
plasmids	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
Xho	NULL
!	NULL

site	NULL
of	NULL
pEFTAG	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
HA	NULL
tag	NULL
,	NULL
resulting	NULL
in	NULL
pEFTAGmNFATI-A	NULL
,	NULL
pEFTAGmNFAT1-B	NULL
,	NULL
and	NULL
pEFTAGmNFAT1-C	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
first	NULL
three	NULL
residues	NULL
of	NULL
NFAT1	NULL
were	NULL
replaced	NULL
by	NULL
amino	NULL
acids	NULL
AQCGRSS	NULL
from	NULL
pEFTAG	NULL
.	NULL

The	NULL
pBLCAT5/NFAT3X	NULL
reporter	NULL
plasmid	NULL
was	NULL
constructed	NULL
by	NULL
subcloning	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
NFAT	NULL
site	NULL
from	NULL
plasmid	NULL
pMILNFAT-CAT	NULL
(	NULL
23	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
in	NULL
pBLCATS3	NULL
plasmid	NULL
(	NULL
57	NULL
)	NULL
,	NULL
a	NULL
gift	NULL
from	NULL
E.	NULL
Serfling	NULL
.	NULL

Plasmid	NULL
5'IL2-CAT	NULL
,	NULL
which	NULL
contains	NULL
sequence	NULL
from	NULL
-576	NULL
to	NULL
+42	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
(	NULL
56	NULL
)	NULL
,	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

Plasmid	NULL
TNFa-Luc	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
sequence	NULL
from	NULL
-614	NULL
to	NULL
+20	NULL
of	NULL
the	NULL
human	NULL
TNF-	NULL
«	NULL
promoter	NULL
in	NULL
pGL2	NULL
,	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

Plasmid	NULL
pSVO-801	NULL
(	NULL
61	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
murine	NULL
IL-4	NULL
promoter	NULL
(	NULL
-801	NULL
to	NULL
+58	NULL
)	NULL
,	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

Plasmid	NULL
pHGM	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
region	NULL
from	NULL
-627	NULL
to	NULL
+29	NULL
bp	NULL
of	NULL
the	NULL
human	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
8	NULL
)	NULL
,	NULL
was	NULL
from	NULL
P.	NULL
N.	NULL
Cockerill	NULL
.	NULL

Plasmid	NULL
pSRe-ACaM-AI	NULL
(	NULL
43	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
R.	NULL
L.	NULL
Kincaid	NULL
;	NULL
plasmids	NULL
pSR	NULL
«	NULL
-CnB	NULL
and	NULL
pSRa	NULL
(	NULL
34	NULL
)	NULL
were	NULL
gifts	NULL
from	NULL
F.	NULL
McKeon	NULL
.	NULL

Transfection	NULL
,	NULL
CAT	NULL
,	NULL
and	NULL
luciferase	NULL
assays	NULL
.	NULL

Jurkat	NULL
and	NULL
COS	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
;	NULL
aliquots	NULL
of	NULL
log-phase	NULL
cells	NULL
were	NULL
frozen	NULL
and	NULL
stored	NULL
in	NULL
liquid	NULL
nitrogen	NULL
.	NULL

Jurkat	NULL
and	NULL
COS	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
10	NULL
mM	NULL
N-2-hydroxyethylpiperazine-V'-2-ethanesulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
and	NULL
50	NULL
M	NULL
2-mercaptocthanol	NULL
(	NULL
Life	NULL
Technology	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
untransformed	NULL
murine	NULL
T-cell	NULL
clone	NULL
Ar-5	NULL
was	NULL
cultured	NULL
in	NULL
IL-2-containing	NULL
medium	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
in	NULL
serum-free	NULL
medium	NULL
in	NULL
0.4-cm	NULL
cuvettes	NULL
with	NULL
settings	NULL
of	NULL
250	NULL
V	NULL
and	NULL
960	NULL
F	NULL
,	NULL
using	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
38	NULL
)	NULL
.	NULL

One	NULL
day	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
overnight	NULL
by	NULL
adding	NULL
ionomycin	NULL
or	NULL
PMA	NULL
to	NULL
cell	NULL
culture	NULL
media	NULL
;	NULL
solvent	NULL
was	NULL
added	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
2	NULL
days	NULL
after	NULL
transfection	NULL
,	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
and	NULL
quantified	NULL
with	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Routinely	NULL
,	NULL
5	NULL
ul	NULL
from	NULL
100	NULL
pl	NULL
of	NULL
cell	NULL
extract	NULL
was	NULL
used	NULL
for	NULL
a	NULL
30-min	NULL
CAT	NULL
assay	NULL
.	NULL

Luciferase	NULL
assays	NULL
were	NULL
done	NULL
with	NULL
a	NULL
luciferase	NULL
assay	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Transfection	NULL
efficiencies	NULL
were	NULL
determined	NULL
by	NULL
cotransfecting	NULL
a	NULL
Rous	NULL
sarcoma	NULL
virus-human	NULL
growth	NULL
hormone	NULL
(	NULL
hGH	NULL
)	NULL
plasmid	NULL
(	NULL
52	NULL
)	NULL
and	NULL
measuring	NULL
the	NULL
hGH	NULL
concentration	NULL
in	NULL
the	NULL
cell	NULL
culture	NULL
medium	NULL
with	NULL
a	NULL
radicimmunometric	NULL
assay	NULL
kit	NULL
(	NULL
Hybritech	NULL
)	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiency	NULL
or	NULL
protein	NULL
amount	NULL
for	NULL
aliquots	NULL
of	NULL
the	NULL
same	NULL
transfection	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
with	NULL
the	NULL
Bradford	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
)	NULL
,	NULL
with	NULL
bovine	NULL
serum	NULL
albumin	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

Antibodies	NULL
and	NULL
Western	NULL
blotting	NULL
(	NULL
immunoblotting	NULL
)	NULL
.	NULL

Polyclonal	NULL
and	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
peptides	NULL
or	NULL
recombinant	NULL
protein	NULL
fragments	NULL
of	NULL
NFAT1	NULL
were	NULL
raised	NULL
and	NULL
purified	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
16	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Antibody	NULL
against	NULL
the	NULL
HA	NULL
epitope	NULL
(	NULL
12CA3	NULL
)	NULL
was	NULL
from	NULL
Bochringer	NULL
Mannheim	NULL
.	NULL

Western	NULL
blotting	NULL
of	NULL
whole-cell	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
lysates	NULL
was	NULL
done	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
16	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Immunocytochemistry	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
attach	NULL
to	NULL
poly-p-lysine-coated	NULL
coverslips	NULL
2	NULL
days	NULL
after	NULL
transfection	NULL
,	NULL
and	NULL
COS	NULL
cells	NULL
were	NULL
grown	NULL
overnight	NULL
on	NULL
uncoated	NULL
coverslips	NULL
1	NULL
day	NULL
after	NULL
transfection	NULL
.	NULL

Attached	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
3	NULL
wM	NULL
ionomycin	NULL
for	NULL
another	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

CsA	NULL
(	NULL
1	NULL
M	NULL
)	NULL
was	NULL
added	NULL
10	NULL
min	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
REGULATION	NULL
OF	NULL
RECOMBINANT	NULL
NFAT1I	NULL
3957	NULL
A	NULL
C	NULL
msm	NULL
aA	NULL
[	NULL
18	NULL
]	NULL
B	NULL
[	NULL
C	NULL
=	NULL
3	NULL
R	NULL
=	NULL
g	NULL
=	NULL
3	NULL
=	NULL
&	NULL
o	NULL
=	NULL
8	NULL
R	NULL
&	NULL
__R	NULL
__	NULL
A	NULL
A4	NULL
_	NULL
__2	NULL
&	NULL
&	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
1	NULL
1000	NULL
2000	NULL
3000	NULL
4000	NULL
bp	NULL
a	NULL
L_____________	NULL
*	NULL
[	NULL
QB	NULL
(	NULL
A	NULL
)	NULL
T2B1	NULL
(	NULL
B	NULL
)	NULL
C	NULL
via1	NULL
(	NULL
C	NULL
)	NULL
R3B1	NULL
(	NULL
C	NULL
)	NULL
b	NULL
sommes	NULL
-	NULL
em-	NULL
-	NULL
~	NULL
Genomic	NULL
C.	NULL
<	NULL
D	NULL
]	NULL
uw	NULL
-LLLLLL__~~J	NULL
]	NULL
R2	NULL
B	NULL
[	NULL
13	NULL
]	NULL
B	NULL
C	NULL
B	NULL
-	NULL
c	NULL
___	NULL
H	NULL
C	NULL
Variant	NULL
C	NULL
=	NULL
!	NULL

3	NULL
Z	NULL
E	NULL
&	NULL
I	NULL
I	NULL
I	NULL
I	NULL
1	NULL
1	NULL
1000	NULL
2000	NULL
3000	NULL
4000	NULL
bp	NULL
O	NULL
]	NULL
21B2	NULL
42	NULL
118A	NULL
[	NULL
103A	NULL
B-like	NULL
C-like	NULL
RT-PCR	NULL
C	NULL
Variant	NULL
CIB	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Strategies	NULL
for	NULL
cloning	NULL
murine	NULL
(	NULL
A	NULL
)	NULL
and	NULL
human	NULL
(	NULL
B	NULL
)	NULL
NFAT1	NULL
.	NULL

The	NULL
ruler	NULL
in	NULL
each	NULL
panel	NULL
shows	NULL
the	NULL
length	NULL
starting	NULL
from	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
compiled	NULL
cDNA	NULL
sequence	NULL
and	NULL
the	NULL
restriction	NULL
sites	NULL
used	NULL
for	NULL
generating	NULL
probes	NULL
and	NULL
subcloning	NULL
.	NULL

The	NULL
coding	NULL
regions	NULL
of	NULL
the	NULL
NFAT1	NULL
isoforms	NULL
are	NULL
shown	NULL
schematically	NULL
above	NULL
the	NULL
ruler	NULL
,	NULL
with	NULL
the	NULL
open	NULL
box	NULL
representing	NULL
the	NULL
common	NULL
region	NULL
and	NULL
the	NULL
filled	NULL
boxes	NULL
with	NULL
different	NULL
patterns	NULL
representing	NULL
the	NULL
alternatively	NULL
spliced	NULL
3	NULL
'	NULL
regions	NULL
encoding	NULL
the	NULL
different	NULL
C	NULL
termini	NULL
.	NULL

The	NULL
partial	NULL
sequence	NULL
of	NULL
the	NULL
short	NULL
human	NULL
C	NULL
variant	NULL
is	NULL
represented	NULL
by	NULL
the	NULL
open-ended	NULL
box	NULL
.	NULL

The	NULL
probes	NULL
used	NULL
for	NULL
screening	NULL
are	NULL
shown	NULL
below	NULL
the	NULL
ruler	NULL
as	NULL
thick	NULL
lines	NULL
designated	NULL
by	NULL
lowercase	NULL
letters	NULL
.	NULL

For	NULL
clarity	NULL
,	NULL
only	NULL
representative	NULL
clones	NULL
isolated	NULL
by	NULL
using	NULL
each	NULL
probe	NULL
are	NULL
shown	NULL
below	NULL
the	NULL
probe	NULL
with	NULL
their	NULL
designations	NULL
.	NULL

Each	NULL
murine	NULL
isoform	NULL
is	NULL
represented	NULL
by	NULL
at	NULL
least	NULL
two	NULL
independently	NULL
isolated	NULL
clones	NULL
.	NULL

Open	NULL
boxes	NULL
represent	NULL
the	NULL
common	NULL
coding	NULL
region	NULL
,	NULL
whereas	NULL
the	NULL
filled	NULL
boxes	NULL
indicate	NULL
the	NULL
alternatively	NULL
spliced	NULL
cDNA	NULL
forms	NULL
,	NULL
with	NULL
the	NULL
same	NULL
pattern	NULL
representing	NULL
the	NULL
same	NULL
sequence	NULL
.	NULL

Open-ended	NULL
boxes	NULL
indicate	NULL
cDNA	NULL
clones	NULL
longer	NULL
than	NULL
shown	NULL
.	NULL

Asterisks	NULL
indicate	NULL
stop	NULL
codons	NULL
.	NULL

Thin	NULL
lines	NULL
represent	NULL
the	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
.	NULL

A	NULL
fragment	NULL
of	NULL
a	NULL
murine	NULL
genomic	NULL
clone	NULL
is	NULL
indicated	NULL
in	NULL
panel	NULL
A	NULL
,	NULL
with	NULL
the	NULL
exon	NULL
shown	NULL
as	NULL
a	NULL
black	NULL
box	NULL
and	NULL
the	NULL
introns	NULL
shown	NULL
as	NULL
dashed	NULL
lines	NULL
.	NULL

The	NULL
arrowheads	NULL
in	NULL
panel	NULL
B	NULL
indicate	NULL
the	NULL
primers	NULL
used	NULL
for	NULL
RT-PCR	NULL
,	NULL
pointing	NULL
in	NULL
the	NULL
direction	NULL
of	NULL
polymerase	NULL
reaction	NULL
,	NULL
and	NULL
the	NULL
primers	NULL
are	NULL
numbered	NULL
as	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
RT-PCR	NULL
products	NULL
from	NULL
Jurkat	NULL
cells	NULL
are	NULL
indicated	NULL
in	NULL
panel	NULL
B	NULL
.	NULL

When	NULL
primer	NULL
2	NULL
was	NULL
used	NULL
as	NULL
the	NULL
5	NULL
'	NULL
primer	NULL
,	NULL
only	NULL
PCR	NULL
products	NULL
corresponding	NULL
to	NULL
the	NULL
fragments	NULL
of	NULL
isoforms	NULL
B	NULL
and	NULL
C	NULL
were	NULL
detected	NULL
.	NULL

before	NULL
treatment	NULL
and	NULL
was	NULL
present	NULL
during	NULL
stimulation	NULL
in	NULL
indicated	NULL
samples	NULL
.	NULL

Cells	NULL
were	NULL
fixed	NULL
immediately	NULL
after	NULL
treatment	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
antibody	NULL
12CA5	NULL
to	NULL
the	NULL
HA	NULL
epitope	NULL
tag	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
55	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
with	NULL
secondary	NULL
antibody	NULL
,	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
Hoechst	NULL
dye	NULL
33342	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
2	NULL
min	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
mounted	NULL
for	NULL
microscopy	NULL
.	NULL

GenBank	NULL
accession	NULL
numbers	NULL
.	NULL

The	NULL
GenBank	NULL
accession	NULL
numbers	NULL
for	NULL
the	NULL
NFAT1	NULL
sequences	NULL
described	NULL
in	NULL
this	NULL
report	NULL
are	NULL
UO2079	NULL
(	NULL
murine	NULL
NFAT1-A	NULL
)	NULL
,	NULL
U36575	NULL
(	NULL
murine	NULL
NFAT1-B	NULL
)	NULL
,	NULL
U36576	NULL
(	NULL
murine	NULL
NFAT1-C	NULL
)	NULL
,	NULL
U43341	NULL
(	NULL
human	NULL
NFAT1-B	NULL
)	NULL
,	NULL
and	NULL
U43342	NULL
(	NULL
human	NULL
NFAT1-C	NULL
)	NULL
.	NULL

RESULTS	NULL
Isolation	NULL
of	NULL
cDNA	NULL
clones	NULL
encoding	NULL
murine	NULL
and	NULL
human	NULL
NFAT1	NULL
.	NULL

Figure	NULL
1A	NULL
summarizes	NULL
the	NULL
alignment	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
representative	NULL
cDNA	NULL
clones	NULL
and	NULL
a	NULL
murine	NULL
genomic	NULL
clone	NULL
used	NULL
to	NULL
deduce	NULL
the	NULL
primary	NULL
sequence	NULL
of	NULL
murine	NULL
NFAT1	NULL
.	NULL

The	NULL
compiled	NULL
murine	NULL
cDNA	NULL
sequence	NULL
has	NULL
an	NULL
open	NULL
reading	NULL
frame	NULL
encoding	NULL
all	NULL
of	NULL
the	NULL
tryptic	NULL
peptides	NULL
obtained	NULL
from	NULL
purified	NULL
murine	NULL
NFAT1	NULL
(	NULL
32	NULL
)	NULL
,	NULL
two	NULL
of	NULL
which	NULL
(	NULL
Y¥-38	NULL
to	NULL
E-45	NULL
and	NULL
A-51	NULL
to	NULL
D-90	NULL
)	NULL
are	NULL
located	NULL
N	NULL
terminal	NULL
to	NULL
the	NULL
previously	NULL
published	NULL
protein	NULL
sequence	NULL
.	NULL

The	NULL
cDNA	NULL
clones	NULL
fall	NULL
into	NULL
three	NULL
classes	NULL
designated	NULL
NFAT1-A	NULL
,	NULL
NFAT1-B	NULL
,	NULL
and	NULL
NFAT1-C	NULL
,	NULL
which	NULL
are	NULL
related	NULL
by	NULL
alternative	NULL
splicing	NULL
at	NULL
a	NULL
common	NULL
site	NULL
in	NULL
the	NULL
coding	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
cDNAs	NULL
for	NULL
NFAT1-B	NULL
and	NULL
NFAT1-C	NULL
also	NULL
share	NULL
extensive	NULL
sequences	NULL
after	NULL
the	NULL
common	NULL
splicing	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

3958	NULL
LUO	NULL
ET	NULL
AL	NULL
.	NULL

1064	NULL
A	NULL
II	NULL
8	NULL
927	NULL
8	NULL
a	NULL
fe	NULL
__	NULL
]	NULL
:	NULL
B	NULL
m	NULL
MDVPEPQPDPDGGDGPGHEPGGSPQDELDFSILFDYDYLNPIEEEPIAHKAISSPSGLAY	NULL
60	NULL
ho	NULL
-NA	NULL
--	NULL
R	NULL
--	NULL
Q	NULL
E	NULL
w	NULL
N	NULL
--	NULL
-VA-P	NULL
--	NULL
-P	NULL
--	NULL
60	NULL
C	NULL
910	NULL
AATSESWVGTERYTERKFWEKKTLVOPGLLPSFLLLGSLSAGPRSQTPSERKPTE	NULL
murine	NULL
A	NULL
EDVPLSCSQTAWCCOHPLGTCPVLPGPLAVEWWEGOLGRGLEPIPWAPDSAGSL	NULL
HEVDSVGLAGVVGMVLLTLMHHFSMDONQTPSPHWORKHKEVASPGWI	NULL
1064	NULL
murine	NULL
B	NULL
910	NULL
ELIDTHLSWIQNIL	NULL
923	NULL
human	NULL
B	NULL
908	NULL
ELIDTHLSWIQNIL	NULL
921	NULL
co	NULL
murine	NULL
C_	NULL
910	NULL
VNEIIRKEFSGPPSRNQT	NULL
927	NULL
human	NULL
_C	NULL
908	NULL
VNEIIRKEFSGPPARNQT	NULL
925	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Primary	NULL
structure	NULL
of	NULL
NFATL	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
protein	NULL
structure	NULL
of	NULL
NFAT1	NULL
.	NULL

Numbers	NULL
indicate	NULL
the	NULL
amino	NULL
acid	NULL
positions	NULL
of	NULL
murine	NULL
NFAT1	NULL
.	NULL

Regions	NULL
defined	NULL
by	NULL
sequence	NULL
analysis	NULL
are	NULL
shown	NULL
in	NULL
boxes	NULL
.	NULL

D/E	NULL
P	NULL
,	NULL
the	NULL
N-terminal	NULL
acidic	NULL
,	NULL
proline-rich	NULL
region	NULL
;	NULL
QP	NULL
,	NULL
the	NULL
glutamine-	NULL
and	NULL
proline-rich	NULL
region	NULL
.	NULL

The	NULL
arrow	NULL
at	NULL
aa	NULL
909	NULL
indicates	NULL
the	NULL
common	NULL
splicing	NULL
site	NULL
.	NULL

The	NULL
short	NULL
forms	NULL
are	NULL
not	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
deduced	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
C	NULL
isoforms	NULL
of	NULL
murine	NULL
(	NULL
top	NULL
)	NULL
and	NULL
human	NULL
(	NULL
bottom	NULL
)	NULL
NFAT1	NULL
.	NULL

Residues	NULL
that	NULL
are	NULL
identical	NULL
in	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
sequences	NULL
are	NULL
indicated	NULL
by	NULL
dashes	NULL
;	NULL
gaps	NULL
are	NULL
indicated	NULL
by	NULL
dots	NULL
.	NULL

The	NULL
two	NULL
tryptic	NULL
peptides	NULL
derived	NULL
from	NULL
the	NULL
N-terminal	NULL
region	NULL
mentioned	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
are	NULL
underlined	NULL
under	NULL
the	NULL
murine	NULL
sequence	NULL
.	NULL

The	NULL
four	NULL
spaced	NULL
leucines	NULL
are	NULL
overlined	NULL
,	NULL
and	NULL
the	NULL
Rel	NULL
similarity	NULL
region	NULL
is	NULL
under-lined	NULL
.	NULL

The	NULL
arrowhead	NULL
above	NULL
the	NULL
murine	NULL
sequence	NULL
indicates	NULL
the	NULL
common	NULL
splicing	NULL
site	NULL
of	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
isoforms	NULL
,	NULL
whereas	NULL
the	NULL
arrow	NULL
below	NULL
the	NULL
human	NULL
sequence	NULL
indicates	NULL
the	NULL
splicing	NULL
site	NULL
for	NULL
the	NULL
short	NULL
variant	NULL
found	NULL
in	NULL
human	NULL
eDNA	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Amino	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
C	NULL
termini	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
isoforms	NULL
after	NULL
the	NULL
common	NULL
splicing	NULL
site	NULL
.	NULL

The	NULL
short	NULL
human	NULL
variant	NULL
has	NULL
the	NULL
same	NULL
C	NULL
terminus	NULL
as	NULL
human	NULL
NFAT1-C.	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

NFAT1-B	NULL
has	NULL
an	NULL
insertion	NULL
of	NULL
85	NULL
bp	NULL
between	NULL
the	NULL
common	NULL
splicing	NULL
site	NULL
and	NULL
the	NULL
sequence	NULL
shared	NULL
with	NULL
NFAT1-C	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

An	NULL
in-frame	NULL
stop	NULL
codon	NULL
terminates	NULL
the	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
NFAT1-B	NULL
within	NULL
this	NULL
insertion	NULL
.	NULL

Starting	NULL
from	NULL
the	NULL
first	NULL
ATG	NULL
codon	NULL
,	NULL
NFAT1-A	NULL
has	NULL
1,064	NULL
amino	NULL
acid	NULL
residues	NULL
,	NULL
NFAT1-B	NULL
has	NULL
923	NULL
residues	NULL
,	NULL
and	NULL
NFAT1-C	NULL
has	NULL
927	NULL
residues	NULL
,	NULL
with	NULL
predicted	NULL
molecular	NULL
masses	NULL
of	NULL
115,045	NULL
,	NULL
99,699	NULL
,	NULL
and	NULL
100,077	NULL
Da	NULL
,	NULL
respec-tively	NULL
,	NULL
and	NULL
they	NULL
differ	NULL
after	NULL
residue	NULL
909	NULL
.	NULL

Overlapping	NULL
cDNA	NULL
clones	NULL
encoding	NULL
the	NULL
human	NULL
homolog	NULL
of	NULL
NFAT1-C	NULL
were	NULL
isolated	NULL
by	NULL
screening	NULL
a	NULL
human	NULL
Jurkat	NULL
T-cell	NULL
cDNA	NULL
library	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
B	NULL
isoform	NULL
was	NULL
also	NULL
expressed	NULL
in	NULL
human	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
RT-PCR	NULL
to	NULL
analyze	NULL
the	NULL
cytosolic	NULL
RNA	NULL
of	NULL
Jurkat	NULL
cells	NULL
.	NULL

Assuming	NULL
that	NULL
murine	NULL
and	NULL
human	NULL
mRNAs	NULL
are	NULL
organized	NULL
similarly	NULL
,	NULL
that	NULL
is	NULL
,	NULL
that	NULL
the	NULL
B	NULL
and	NULL
C	NULL
isoforms	NULL
share	NULL
a	NULL
region	NULL
of	NULL
3	NULL
'	NULL
untranslated	NULL
sequence	NULL
,	NULL
we	NULL
used	NULL
two	NULL
antisense	NULL
primers	NULL
downstream	NULL
of	NULL
the	NULL
stop	NULL
codon	NULL
of	NULL
NFAT1-C	NULL
and	NULL
sense	NULL
primers	NULL
in	NULL
the	NULL
coding	NULL
region	NULL
for	NULL
RT-PCR	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
showed	NULL
that	NULL
both	NULL
the	NULL
human	NULL
B	NULL
and	NULL
C	NULL
isoforms	NULL
of	NULL
NFAT1	NULL
were	NULL
represented	NULL
.	NULL

Human	NULL
NFATI-B	NULL
and	NULL
NFATI-C	NULL
have	NULL
921	NULL
and	NULL
925	NULL
residues	NULL
,	NULL
with	NULL
predicted	NULL
molecular	NULL
masses	NULL
of	NULL
99,817	NULL
and	NULL
100,178	NULL
Da	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
first	NULL
ATG	NULL
in	NULL
the	NULL
cDNA	NULL
was	NULL
assigned	NULL
as	NULL
the	NULL
start	NULL
codon	NULL
,	NULL
although	NULL
there	NULL
are	NULL
no	NULL
in-frame	NULL
stop	NULL
codons	NULL
in	NULL
the	NULL
upstream	NULL
sequences	NULL
of	NULL
70	NULL
bp	NULL
(	NULL
murine	NULL
)	NULL
or	NULL
220	NULL
bp	NULL
(	NULL
human	NULL
)	NULL
in	NULL
the	NULL
isolated	NULL
cDNAs	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
assignment	NULL
,	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
cDNA	NULL
sequences	NULL
diverge	NULL
upstream	NULL
of	NULL
the	NULL
first	NULL
ATG	NULL
codon	NULL
.	NULL

Furthermore	NULL
,	NULL
when	NULL
human	NULL
NFAT1-B	NULL
and	NULL
NFAT1-C	NULL
were	NULL
expressed	NULL
in	NULL
COS	NULL
cells	NULL
with	NULL
an	NULL
engineered	NULL
ATG	NULL
codon	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
isolated	NULL
cDNAs	NULL
,	NULL
the	NULL
resulting	NULL
proteins	NULL
migrated	NULL
on	NULL
SDS-polyacrylamide	NULL
gels	NULL
with	NULL
a	NULL
higher	NULL
apparent	NULL
molecular	NULL
weight	NULL
than	NULL
T-cell	NULL
NFAT1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
COS	NULL
cell	NULL
expression	NULL
of	NULL
NFAT1-B	NULL
or	NULL
NFAT1I-C	NULL
starting	NULL
with	NULL
the	NULL
assigned	NULL
ATG	NULL
codon	NULL
yielded	NULL
proteins	NULL
migrating	NULL
with	NULL
the	NULL
same	NULL
apparent	NULL
molecular	NULL
weight	NULL
as	NULL
endogenous	NULL
T-cell	NULL
NFAT1	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

We	NULL
)	NULL
a1s0	NULL
isolated	NULL
several	NULL
cDNA	NULL
inserts	NULL
,	NULL
representing	NULL
a	NULL
short	NULL
variant	NULL
of	NULL
human	NULL
NFAT1	NULL
cDNA	NULL
,	NULL
from	NULL
the	NULL
Jurkat	NULL
cDNA	NULL
library	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

These	NULL
cDNAs	NULL
encode	NULL
an	NULL
apparent	NULL
splicing	NULL
variant	NULL
of	NULL
the	NULL
C	NULL
isoform	NULL
,	NULL
lacking	NULL
sequences	NULL
between	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
Rel	NULL
similarity	NULL
region	NULL
and	NULL
the	NULL
common	NULL
splicing	NULL
site	NULL
of	NULL
the	NULL
three	NULL
isoforms	NULL
identified	NULL
in	NULL
mouse	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
similar	NULL
variants	NULL
were	NULL
not	NULL
isolated	NULL
from	NULL
the	NULL
murine	NULL
T-cell	NULL
cDNA	NULL
library	NULL
,	NULL
and	NULL
there	NULL
is	NULL
no	NULL
evidence	NULL
that	NULL
a	NULL
corresponding	NULL
short	NULL
form	NULL
of	NULL
the	NULL
protein	NULL
is	NULL
expressed	NULL
in	NULL
murine	NULL
and	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Structure	NULL
of	NULL
NFAT1	NULL
.	NULL

Figure	NULL
2A	NULL
shows	NULL
a	NULL
schematic	NULL
diagram	NULL
of	NULL
the	NULL
predicted	NULL
structure	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
NFAT1	NULL
.	NULL

The	NULL
human	NULL
and	NULL
murine	NULL
proteins	NULL
show	NULL
90	NULL
%	NULL
identity	NULL
in	NULL
their	NULL
amino	NULL
acid	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
region	NULL
spanning	NULL
the	NULL
first	NULL
100	NULL
amino	NULL
acids	NULL
(	NULL
aa	NULL
)	NULL
of	NULL
NFAT1	NULL
(	NULL
designated	NULL
D/E	NULL
P	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
is	NULL
rich	NULL
in	NULL
acidic	NULL
(	NULL
19	NULL
%	NULL
)	NULL
and	NULL
proline	NULL
(	NULL
17	NULL
%	NULL
)	NULL
residues	NULL
and	NULL
shows	NULL
little	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
corresponding	NULL
regions	NULL
of	NULL
other	NULL
NFAT	NULL
family	NULL
members	NULL
(	NULL
18	NULL
,	NULL
28	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
central	NULL
region	NULL
of	NULL
NFAT1	NULL
contains	NULL
the	NULL
DNA-binding	NULL
domain	NULL
(	NULL
aa	NULL
410	NULL
to	NULL
679	NULL
of	NULL
murine	NULL
NFAT1	NULL
)	NULL
,	NULL
which	NULL
shows	NULL
a	NULL
strong	NULL
homology	NULL
within	NULL
the	NULL
NFAT	NULL
family	NULL
(	NULL
18	NULL
,	NULL
28	NULL
,	NULL
41	NULL
)	NULL
and	NULL
a	NULL
weak	NULL
resemblance	NULL
to	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
as	NULL
noted	NULL
before	NULL
(	NULL
18	NULL
,	NULL
20	NULL
,	NULL
40	NULL
)	NULL
.	NULL

NFAT1	NULL
contains	NULL
a	NULL
C-terminal	NULL
region	NULL
of	NULL
over	NULL
200	NULL
aa	NULL
(	NULL
designated	NULL
QP	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
that	NULL
is	NULL
rich	NULL
in	NULL
glutamine	NULL
(	NULL
15	NULL
%	NULL
)	NULL
and	NULL
proline	NULL
(	NULL
11	NULL
%	NULL
)	NULL
.	NULL

This	NULL
region	NULL
does	NULL
not	NULL
exist	NULL
in	NULL
NFATe	NULL
(	NULL
41	NULL
)	NULL
and	NULL
has	NULL
little	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
C-terminal	NULL
regions	NULL
of	NULL
NFAT3	NULL
or	NULL
NFATx/4/c3	NULL
(	NULL
17	NULL
,	NULL
18	NULL
,	NULL
28	NULL
)	NULL
.	NULL

NFAT1I-B	NULL
and	NULL
NFATI-C	NULL
have	NULL
very	NULL
short	NULL
unique	NULL
sequences	NULL
after	NULL
the	NULL
splicing	NULL
site	NULL
,	NULL
whereas	NULL
NFATI-A	NULL
has	NULL
155	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
unique	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Sequence	NULL
comparison	NULL
of	NULL
NFAT	NULL
family	NULL
proteins	NULL
revealed	NULL
another	NULL
conserved	NULL
region	NULL
(	NULL
approximately	NULL
aa	NULL
102	NULL
to	NULL
406	NULL
of	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
NFATL	NULL
:	NULL
SGL	NULL
-	NULL
SERIEHIRPSHEL	NULL
IQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVS-GFE	NULL
159	NULL
NFAT	NULL
:	NULL
PAL	NULL
ES	NULL
GL	NULL
163	NULL
NFAT3	NULL
:	NULL
SPTPEPPAAL	NULL
EDNPDAWGDG	NULL
--	NULL
--	NULL
--	NULL
~-~-	NULL
SPR-DYPPMEGE-	NULL
152	NULL
NFAT4	NULL
:	NULL
PL	NULL
A6PKPF	NULL
E	NULL
CBSNIQINIS	NULL
T	NULL
SPNCHOQELDA-HEDDLQINDPEREFL	NULL
ERPS-RDHLYL	NULL
@	NULL
--	NULL
LE	NULL
154	NULL
is	NULL
NFATL	NULL
:	NULL
HSA	NULL
F	NULL
——————————————————————————	NULL
183	NULL
NFATo	NULL
:	NULL
-AMMWPSC	NULL
--	NULL
--	NULL
--	NULL
L——	NULL
SSYESNYSYPYA	NULL
———————————	NULL
SPQT	NULL
202	NULL
NFAT3	NULL
:	NULL
GOMMSAGAQGGGAFF	NULL
SPESGSSEL	NULL
SDEAALYAACDEVESELNEAASRFGLG	NULL
212	NULL
NFAT4	NULL
:	NULL
P	NULL
MHS-SS	NULL
--	NULL
-	NULL
--	NULL
-	NULL
LSP	NULL
-T	NULL
SSCESLSHIYDDVDSELNEAAARFTLG	NULL
206	NULL
nFaTL	NULL
:	NULL
BEVTERCVEBNNGGPNL	NULL
CPQFQNIPAHY	NULL
-	NULL
SPRT	NULL
SP	NULL
IMEBRT	NULL
SL	NULL
ANSC	NULL
RHSPVPRPA	NULL
242	NULL
NFATe	NULL
:	NULL
-	NULL
GACTL	NULL
L	NULL
GSPQHSPS	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
S	NULL
256	NULL
NFAT3	NULL
:	NULL
NFAT4	NULL
:	NULL
LTGG	NULL
HGGCP	NULL
PWS-LYG-P	NULL
--	NULL
-~-~	NULL
--	NULL
--	NULL
~~	NULL
258	NULL
WHQQYGLGHSL	NULL
-	NULL
SPRQSPCH	NULL
RSSVTINSNWIIS-PRPASGPS	NULL
264	NULL
nrati	NULL
:	NULL
VAL	NULL
PPGASPQRSRSPEROPESHVAPQRHGSPAGYPPVAGSA	NULL
301	NULL
NFATe	NULL
:	NULL
|	NULL
W-WP	NULL
.	NULL

-	NULL
-	NULL
-	NULL
PP	NULL
-	NULL
Y	NULL
SPHHSPTPESHGEPRVSVTIEDSWLGNTTQYTSSA	NULL
311	NULL
NEAT3	NULL
:	NULL
--	NULL
--	NULL
-	NULL
PSSA	NULL
--	NULL
--	NULL
--	NULL
-	NULL
GHEGSEPPPPPPLPLA	NULL
306	NULL
nraTA	NULL
:	NULL
|	NULL
-	NULL
-	NULL
GSL	NULL
RGS	NULL
V	NULL
TBD	NULL
PRGSVTISDTWLNASVH-GGSG	NULL
320	NULL
NEAT1	NULL
:	NULL
VIMDALNSLATDS	NULL
--	NULL
-PC-GI	NULL
@	NULL
PB	NULL
PRPSPVSAAPSHAGLPRHIYPAVEFLGPCEQ	NULL
357	NULL
NFAT	NULL
:	NULL
IV-	NULL
AAINALTTDSSLDLGDGVELEPPSVAL	NULL
``	NULL
gEPVGEDLGSPPPPADFAP	NULL
368	NULL
wrars	NULL
:	NULL
SBQ	NULL
--	NULL
AVALP-H	NULL
--	NULL
--	NULL
SEEPASCNGKLPLGA	NULL
358	NULL
wramaé	NULL
:	NULL
LGPAV-FPFQYCVE	NULL
--	NULL
-TD-	NULL
ISLM	NULL
--	NULL
AAILPGLELCSDDQGSLSPARETSI	NULL
373	NULL
NFATL	NULL
:	NULL
6	NULL
@	NULL
--	NULL
--	NULL
--	NULL
--	NULL
EENSAPES	NULL
TIL	NULL
US-	NULL
404	NULL
NFATc	NULL
:	NULL
E	NULL
SSFQH-IERGGFCDQY	NULL
KPLPL	NULL
SPTS	NULL
-	NULL
YMS	NULL
-P	NULL
-	NULL
pj	NULL
-	NULL
-	NULL
lid	NULL
LDW	NULL
SH	NULL
422	NULL
NFAT3	NULL
:	NULL
ESSVAPPGGSEBIEVAGMDY	NULL
]	NULL
S	NULL
LASSKAZ-IGGHSPIFR	NULL
-	NULL
-	NULL
-	NULL
LP	NULL
‘	NULL
LD	NULL
pMPSQ	NULL
413	NULL
wrata	NULL
:	NULL
SCGDQF	NULL
-	NULL
uF	NULL
THIS	NULL
KPIP	NULL
-	NULL
-	NULL
GHT	NULL
PT	NULL
FR	NULL
-	NULL
-	NULL
-	NULL
NIS	NULL
S	NULL
P	NULL
AH	NULL
427	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Sequence	NULL
alignment	NULL
of	NULL
the	NULL
NHR	NULL
of	NULL
human	NULL
NFAT1	NULL
,	NULL
NFATs	NULL
,	NULL
NFAT3	NULL
,	NULL
and	NULL
(	NULL
labeled	NULL
NFAT4	NULL
)	NULL
.	NULL

Residues	NULL
conserved	NULL
in	NULL
all	NULL
four	NULL
sequences	NULL
or	NULL
showing	NULL
only	NULL
K/R	NULL
or	NULL
D/E	NULL
substitutions	NULL
are	NULL
highlighted	NULL
as	NULL
white	NULL
letters	NULL
against	NULL
a	NULL
black	NULL
background	NULL
.	NULL

Dashes	NULL
represent	NULL
gaps	NULL
introduced	NULL
into	NULL
the	NULL
sequences	NULL
to	NULL
optimize	NULL
sequence	NULL
alignment	NULL
.	NULL

The	NULL
lines	NULL
under	NULL
the	NULL
sequences	NULL
indicate	NULL
the	NULL
SP	NULL
motifs	NULL
and	NULL
other	NULL
motifs	NULL
mentioned	NULL
in	NULL
the	NULL
text	NULL
.	NULL

The	NULL
numbers	NULL
on	NULL
the	NULL
right	NULL
indicate	NULL
the	NULL
amino	NULL
acid	NULL
numbers	NULL
of	NULL
the	NULL
last	NULL
residues	NULL
of	NULL
the	NULL
respective	NULL
lines	NULL
.	NULL

All	NULL
isoforms	NULL
of	NULL
NFAT1	NULL
possess	NULL
the	NULL
same	NULL
NHR	NULL
sequences	NULL
,	NULL
as	NULL
do	NULL
all	NULL
isoforms	NULL
of	NULL
NFAT4	NULL
(	NULL
including	NULL
NFATs	NULL
and	NULL
NFATe3	NULL
)	NULL
.	NULL

human	NULL
NFAT1	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
just	NULL
N	NULL
terminal	NULL
to	NULL
the	NULL
DNA-binding	NULL
domain	NULL
.	NULL

This	NULL
region	NULL
,	NULL
designated	NULL
the	NULL
NFAT	NULL
homology	NULL
region	NULL
(	NULL
NHR	NULL
)	NULL
,	NULL
is	NULL
rich	NULL
in	NULL
serine	NULL
and	NULL
proline	NULL
and	NULL
is	NULL
found	NULL
only	NULL
in	NULL
NFAT	NULL
family	NULL
proteins	NULL
.	NULL

The	NULL
NHR	NULL
shows	NULL
~30	NULL
to	NULL
40	NULL
%	NULL
pairwise	NULL
sequence	NULL
identity	NULL
between	NULL
NFAT1	NULL
and	NULL
other	NULL
NFAT	NULL
family	NULL
members	NULL
,	NULL
and	NULL
the	NULL
conserved	NULL
residues	NULL
are	NULL
clustered	NULL
in	NULL
conserved	NULL
sequence	NULL
motifs	NULL
(	NULL
underlined	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Among	NULL
these	NULL
motifs	NULL
are	NULL
the	NULL
three	NULL
repeats	NULL
of	NULL
the	NULL
SP	NULL
motif	NULL
with	NULL
a	NULL
consensus	NULL
sequence	NULL
SPxxSPxxSPxxxxx	NULL
(	NULL
D/E	NULL
)	NULL
(	NULL
D/E	NULL
)	NULL
as	NULL
noted	NULL
before	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
second	NULL
and	NULL
third	NULL
SP	NULL
motifs	NULL
are	NULL
incomplete	NULL
in	NULL
NFAT3	NULL
.	NULL

The	NULL
spacing	NULL
between	NULL
these	NULL
repeats	NULL
is	NULL
not	NULL
tightly	NULL
conserved	NULL
.	NULL

N	NULL
terminal	NULL
to	NULL
the	NULL
first	NULL
SP	NULL
motif	NULL
is	NULL
a	NULL
serine-rich	NULL
motif	NULL
with	NULL
a	NULL
consensus	NULL
sequence	NULL
of	NULL
SPxS	NULL
(	NULL
s	NULL
)	NULL
SxSSxSxxS	NULL
(	NULL
D/E	NULL
)	NULL
(	NULL
residue	NULL
168	NULL
to	NULL
181	NULL
in	NULL
human	NULL
NFAT1	NULL
)	NULL
.	NULL

Flanking	NULL
the	NULL
third	NULL
SP	NULL
motif	NULL
are	NULL
two	NULL
motifs	NULL
rich	NULL
in	NULL
basic	NULL
residues	NULL
,	NULL
one	NULL
with	NULL
a	NULL
consensus	NULL
sequence	NULL
of	NULL
Rxx-SPxxKR	NULL
(	NULL
R/K	NULL
)	NULL
xS	NULL
(	NULL
residue	NULL
244	NULL
to	NULL
255	NULL
in	NULL
human	NULL
NFAT1	NULL
)	NULL
and	NULL
the	NULL
other	NULL
with	NULL
a	NULL
consensus	NULL
sequence	NULL
of	NULL
IPxKxxKT	NULL
(	NULL
S/T	NULL
)	NULL
xD	NULL
(	NULL
residue	NULL
318	NULL
to	NULL
328	NULL
in	NULL
human	NULL
NFAT1	NULL
)	NULL
.	NULL

The	NULL
NHR	NULL
begins	NULL
with	NULL
a	NULL
motif	NULL
of	NULL
PxIxIT	NULL
(	NULL
aa	NULL
111	NULL
to	NULL
116	NULL
in	NULL
human	NULL
NFAT1	NULL
)	NULL
which	NULL
is	NULL
followed	NULL
by	NULL
a	NULL
conserved	NULL
YR	NULL
(	NULL
E/D	NULL
)	NULL
motif	NULL
.	NULL

Strong	NULL
homology	NULL
is	NULL
also	NULL
found	NULL
in	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
the	NULL
NHR	NULL
which	NULL
is	NULL
adjacent	NULL
to	NULL
the	NULL
Rel	NULL
similarity	NULL
region	NULL
.	NULL

The	NULL
NHR	NULL
of	NULL
NFAT1	NULL
also	NULL
contains	NULL
a	NULL
sequence	NULL
of	NULL
four	NULL
leucine	NULL
residues	NULL
(	NULL
L-121	NULL
to	NULL
L-142	NULL
;	NULL
overlined	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
spaced	NULL
in	NULL
a	NULL
heptad	NULL
repeat	NULL
that	NULL
is	NULL
not	NULL
found	NULL
in	NULL
the	NULL
other	NULL
NFAT	NULL
family	NULL
proteins	NULL
.	NULL

Although	NULL
the	NULL
interspersed	NULL
glycine	NULL
and	NULL
proline	NULL
residues	NULL
within	NULL
this	NULL
sequence	NULL
suggest	NULL
that	NULL
it	NULL
does	NULL
not	NULL
form	NULL
a	NULL
helical	NULL
leucine	NULL
zipper	NULL
,	NULL
it	NULL
is	NULL
intriguing	NULL
that	NULL
both	NULL
RelA	NULL
and	NULL
ReIB	NULL
have	NULL
similar	NULL
leucine	NULL
zipper-like	NULL
motifs	NULL
that	NULL
are	NULL
required	NULL
for	NULL
their	NULL
transactivation	NULL
activities	NULL
(	NULL
10	NULL
,	NULL
50	NULL
)	NULL
.	NULL

The	NULL
corresponding	NULL
regions	NULL
in	NULL
other	NULL
NFAT	NULL
family	NULL
proteins	NULL
are	NULL
rich	NULL
in	NULL
acidic	NULL
residues	NULL
.	NULL

Expression	NULL
of	NULL
NFAT1	NULL
protein	NULL
.	NULL

Experiments	NULL
in	NULL
which	NULL
immu-noprecipitation	NULL
of	NULL
NFAT1	NULL
with	NULL
one	NULL
antiserum	NULL
was	NULL
followed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
an	NULL
antiserum	NULL
recognizing	NULL
a	NULL
different	NULL
REGULATION	NULL
OF	NULL
RECOMBINANT	NULL
NFAT1I	NULL
3959	NULL
region	NULL
of	NULL
the	NULL
protein	NULL
confirmed	NULL
that	NULL
isoforms	NULL
B	NULL
and	NULL
C	NULL
of	NULL
NFAT1	NULL
contained	NULL
the	NULL
N-terminal	NULL
peptide	NULL
and	NULL
the	NULL
DNA-binding	NULL
domain	NULL
(	NULL
64	NULL
)	NULL
.	NULL

These	NULL
two	NULL
isoforms	NULL
,	NULL
which	NULL
comigrate	NULL
on	NULL
SDS-gels	NULL
,	NULL
constitute	NULL
the	NULL
bulk	NULL
of	NULL
the	NULL
NFAT1	NULL
detected	NULL
by	NULL
Western	NULL
blotting	NULL
in	NULL
human	NULL
and	NULL
murine	NULL
T-cell	NULL
lines	NULL
.	NULL

Both	NULL
isoforms	NULL
are	NULL
expressed	NULL
in	NULL
murine	NULL
spleen	NULL
and	NULL
thymus	NULL
and	NULL
in	NULL
some	NULL
nervous	NULL
system	NULL
cells	NULL
but	NULL
are	NULL
not	NULL
detected	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
other	NULL
organs	NULL
or	NULL
tissues	NULL
(	NULL
16	NULL
,	NULL
64	NULL
)	NULL
.	NULL

NFAT1-B	NULL
and	NULL
NFAT1-C	NULL
have	NULL
been	NULL
found	NULL
in	NULL
several	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
lineage	NULL
cells	NULL
,	NULL
including	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
natural	NULL
killer	NULL
cells	NULL
,	NULL
mast	NULL
cells	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
macro-phages	NULL
(	NULL
55	NULL
,	NULL
64	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
NFAT1	NULL
may	NULL
play	NULL
a	NULL
general	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
transcription	NULL
of	NULL
cytokine	NULL
genes	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Western	NULL
analysis	NULL
of	NULL
extracts	NULL
from	NULL
unstimulated	NULL
human	NULL
Jurkat	NULL
cells	NULL
,	NULL
using	NULL
antisera	NULL
against	NULL
the	NULL
N-terminal	NULL
and	NULL
C-terminal	NULL
peptides	NULL
or	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
NFAT1	NULL
,	NULL
did	NULL
not	NULL
reveal	NULL
a	NULL
protein	NULL
corresponding	NULL
in	NULL
size	NULL
(	NULL
~80	NULL
kDa	NULL
)	NULL
to	NULL
the	NULL
isoform	NULL
that	NULL
would	NULL
be	NULL
encoded	NULL
by	NULL
the	NULL
shorter	NULL
variant	NULL
NFAT1	NULL
cDNA	NULL
,	NULL
nor	NULL
was	NULL
such	NULL
a	NULL
protein	NULL
detected	NULL
in	NULL
human	NULL
Epstein-Barr	NULL
virus-transformed	NULL
B	NULL
cells	NULL
,	NULL
in	NULL
murine	NULL
Ar-5	NULL
T	NULL
cells	NULL
,	NULL
or	NULL
in	NULL
Ar-5	NULL
cells	NULL
stimulated	NULL
for	NULL
up	NULL
to	NULL
5	NULL
h	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
,	NULL
including	NULL
ionomycin	NULL
,	NULL
immobilized	NULL
anti-CD3	NULL
antibodies	NULL
,	NULL
or	NULL
IL-2	NULL
(	NULL
3a	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
variant	NULL
human	NULL
cDNA	NULL
may	NULL
represent	NULL
a	NULL
splicing	NULL
variant	NULL
that	NULL
is	NULL
not	NULL
normally	NULL
expressed	NULL
as	NULL
protein	NULL
,	NULL
and	NULL
we	NULL
focused	NULL
our	NULL
subsequent	NULL
analyses	NULL
on	NULL
the	NULL
long	NULL
isoforms	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
noteworthy	NULL
that	NULL
NFAT4	NULL
cDNAs	NULL
(	NULL
18	NULL
)	NULL
display	NULL
alternative	NULL
splicing	NULL
at	NULL
the	NULL
corresponding	NULL
site	NULL
and	NULL
that	NULL
NFATc	NULL
(	NULL
41	NULL
)	NULL
has	NULL
only	NULL
a	NULL
short	NULL
C-terminal	NULL
sequence	NULL
following	NULL
the	NULL
DNA-binding	NULL
domain	NULL
,	NULL
like	NULL
the	NULL
predicted	NULL
variant	NULL
NFAT1	NULL
protein	NULL
.	NULL

Transactivation	NULL
and	NULL
regulation	NULL
of	NULL
NFAT1	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

We	NULL
first	NULL
examined	NULL
the	NULL
function	NULL
of	NULL
NFAT1	NULL
by	NULL
transient	NULL
transfection	NULL
of	NULL
COS	NULL
cells	NULL
,	NULL
which	NULL
do	NULL
not	NULL
express	NULL
detectable	NULL
endogenous	NULL
NFAT1	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

NFAT1-B	NULL
and	NULL
NFAT1-C	NULL
expressed	NULL
in	NULL
COS	NULL
cells	NULL
are	NULL
similar	NULL
in	NULL
apparent	NULL
molecular	NULL
weight	NULL
to	NULL
NFAT1	NULL
from	NULL
resting	NULL
murine	NULL
Ar-5	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
migrates	NULL
as	NULL
a	NULL
single	NULL
band	NULL
of	NULL
~140	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
;	NULL
compare	NULL
lanes	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
with	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

NFAT1-A	NULL
is	NULL
expressible	NULL
in	NULL
COS	NULL
cells	NULL
but	NULL
at	NULL
a	NULL
much	NULL
lower	NULL
level	NULL
and	NULL
is	NULL
larger	NULL
than	NULL
the	NULL
other	NULL
two	NULL
isoforms	NULL
and	NULL
the	NULL
endogenous	NULL
NFAT1	NULL
in	NULL
Ar-5	NULL
cells	NULL
,	NULL
most	NULL
likely	NULL
because	NULL
of	NULL
its	NULL
long	NULL
unique	NULL
C	NULL
terminus	NULL
,	NULL
which	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
its	NULL
lower	NULL
level	NULL
of	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
7	NULL
)	NULL
.	NULL

NFAT1	NULL
in	NULL
stimulated	NULL
Ar-5	NULL
T	NULL
cells	NULL
showed	NULL
a	NULL
decrease	NULL
in	NULL
apparent	NULL
molecular	NULL
weight	NULL
to	NULL
~120,000	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
which	NULL
is	NULL
caused	NULL
by	NULL
dephosphorylation	NULL
(	NULL
51	NULL
,	NULL
55	NULL
)	NULL
;	NULL
likewise	NULL
,	NULL
COS	NULL
cell-expressed	NULL
NFAT1-B	NULL
and	NULL
NFAT1I-C	NULL
showed	NULL
a	NULL
similar	NULL
decrease	NULL
in	NULL
apparent	NULL
molecular	NULL
weight	NULL
upon	NULL
treatment	NULL
with	NULL
calcineurin	NULL
in	NULL
vitro	NULL
(	NULL
26a	NULL
)	NULL
.	NULL

The	NULL
single	NULL
bands	NULL
corresponding	NULL
to	NULL
the	NULL
phosphorylated	NULL
and	NULL
dephosphorylated	NULL
forms	NULL
of	NULL
NFAT1	NULL
are	NULL
recognized	NULL
by	NULL
antibodies	NULL
directed	NULL
against	NULL
the	NULL
unique	NULL
C	NULL
termini	NULL
of	NULL
isoforms	NULL
B	NULL
and	NULL
C	NULL
but	NULL
not	NULL
by	NULL
antibodies	NULL
directed	NULL
against	NULL
several	NULL
unique	NULL
C-terminal	NULL
peptides	NULL
of	NULL
isoform	NULL
A	NULL
(	NULL
64	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
A	NULL
isoform	NULL
is	NULL
a	NULL
minor	NULL
component	NULL
in	NULL
T	NULL
cells	NULL
;	NULL
therefore	NULL
,	NULL
for	NULL
subsequent	NULL
analyses	NULL
,	NULL
we	NULL
focused	NULL
on	NULL
isoforms	NULL
B	NULL
and	NULL
C.	NULL
The	NULL
transactivation	NULL
activity	NULL
of	NULL
each	NULL
of	NULL
the	NULL
NFAT1	NULL
isoforms	NULL
was	NULL
assayed	NULL
by	NULL
measuring	NULL
CAT	NULL
activity	NULL
in	NULL
COS	NULL
cells	NULL
cotransfected	NULL
with	NULL
a	NULL
NFAT1	NULL
expression	NULL
plasmid	NULL
and	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
NFAT	NULL
site	NULL
.	NULL

Each	NULL
isoform	NULL
of	NULL
NFAT1	NULL
was	NULL
able	NULL
to	NULL
stimulate	NULL
CAT	NULL
gene	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
.	NULL

In	NULL
several	NULL
independent	NULL
transfection	NULL
experiments	NULL
,	NULL
NFAT1-C	NULL
stimulated	NULL
CAT	NULL
gene	NULL
expression	NULL
by	NULL
5-	NULL
to	NULL
16-fold	NULL
over	NULL
the	NULL
basal	NULL
level	NULL
.	NULL

The	NULL
level	NULL
of	NULL
transactivation	NULL
by	NULL
NFATI-C	NULL
increased	NULL
as	NULL
a	NULL
function	NULL
of	NULL
the	NULL
level	NULL
of	NULL
NFAT1-C	NULL
protein	NULL
expressed	NULL
in	NULL
COS	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

The	NULL
low	NULL
transactivation	NULL
activity	NULL
of	NULL
NFAT1-A	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
could	NULL
reflect	NULL
its	NULL
low	NULL
level	NULL
of	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
possible	NULL
,	NULL
however	NULL
,	NULL
to	NULL
compare	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
transactivation	NULL
by	NULL
the	NULL
different	NULL
isoforms	NULL
,	NULL
since	NULL
transactivation	NULL
depends	NULL
not	NULL
only	NULL
3960	NULL
LUO	NULL
ET	NULL
AL	NULL
.	NULL

m	NULL
A	NULL
_	NULL
Ar5	NULL
transfected	NULL
COS	NULL
cells	NULL
-B	NULL
L	NULL
ff	NULL
/	NULL
|	NULL
<	NULL
om	NULL
9	NULL
<	NULL
@	NULL
9	NULL
£	NULL
E	NULL
g	NULL
E	NULL
6	NULL
mos	NULL
s=	NULL
mur	NULL
a-	NULL
g	NULL
in	NULL
z	NULL
§	NULL
g	NULL
&	NULL
L7	NULL
:	NULL
LT	NULL
:	NULL
E	NULL
E	NULL
t	NULL
:	NULL
l	NULL
<	NULL
_	NULL
(	NULL
2	NULL
5	NULL
§	NULL
&	NULL
K	NULL
LK	NULL
£	NULL
L	NULL
L	NULL
(	NULL
kDa	NULL
)	NULL
3	NULL
2	NULL
S	NULL
Z2	NULL
Z	NULL
Z	NULL
Z	NULL
zZ	NULL
Z	NULL
L	NULL
J	NULL
P20	NULL
66-	NULL
2	NULL
3	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
60	NULL
7	NULL
8	NULL
9	NULL
CAT	NULL
activity	NULL
%	NULL
conversion	NULL
'~	NULL
3.3	NULL
9.1	NULL
C	NULL
g	NULL
``	NULL
NFAT1	NULL
DNA	NULL
(	NULL
ng	NULL
)	NULL
1	NULL
ng	NULL
®	NULL
o	NULL
o	NULL
S	NULL
I	NULL
--	NULL
NFAT1	NULL
5	NULL
20	NULL
o	NULL
o	NULL
6	NULL
o	NULL
56	NULL
>	NULL
-	NULL
a	NULL
-	NULL
a	NULL
~	NULL
©	NULL
:	NULL
~	NULL
]	NULL
|-	NULL
--	NULL
a	NULL
&	NULL
C	NULL
210	NULL
2	NULL
#	NULL
§	NULL
s	NULL
/	NULL
i-	NULL
7	NULL
8	NULL
o	NULL
/	NULL
m	NULL
vector	NULL
I	NULL
``	NULL
s	NULL
a	NULL
Con	NULL
T	NULL
ton	NULL
C	NULL
Groat	NULL
10	NULL
100	NULL
1000	NULL
NFAT1-C	NULL
DNA	NULL
transfected	NULL
(	NULL
ng	NULL
)	NULL
nnatimiulataa	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Expression	NULL
and	NULL
transactivation	NULL
activity	NULL
of	NULL
NFAT1	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Expression	NULL
of	NULL
the	NULL
NFAT1	NULL
isoforms	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
pBLCAT5/NFAT3X	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
expression	NULL
plasmid	NULL
for	NULL
each	NULL
NFAT1	NULL
isoform	NULL
or	NULL
vector	NULL
control	NULL
.	NULL

Two	NULL
days	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
NFAT1	NULL
expression	NULL
was	NULL
assessed	NULL
by	NULL
Western	NULL
analysis	NULL
using	NULL
anti-67.1	NULL
antibody	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
2	NULL
contain	NULL
lysates	NULL
from	NULL
resting	NULL
and	NULL
ionomycin-stimulated	NULL
Ar-5	NULL
T	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
arrowhead	NULL
indicates	NULL
NFAT1	NULL
from	NULL
resting	NULL
Ar-5	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
arrow	NULL
indicates	NULL
dephosphorylated	NULL
NFAT1	NULL
from	NULL
fonomycin-stimulated	NULL
Ar-5	NULL
cells	NULL
.	NULL

Lysates	NULL
of	NULL
4.8	NULL
X	NULL
10°	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
)	NULL
or	NULL
1.2	NULL
x	NULL
10°	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
transfected	NULL
COS	NULL
cells	NULL
were	NULL
loaded	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
transfection	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transactivation	NULL
mediated	NULL
by	NULL
NFAT1	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
as	NULL
in	NULL
panel	NULL
A	NULL
,	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
made	NULL
2	NULL
days	NULL
later	NULL
for	NULL
assay	NULL
of	NULL
CAT	NULL
activity	NULL
,	NULL
which	NULL
is	NULL
shown	NULL
as	NULL
percent	NULL
conversion	NULL
under	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
transfection	NULL
experiments	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Transactivation	NULL
as	NULL
a	NULL
function	NULL
of	NULL
the	NULL
level	NULL
of	NULL
NFAT1	NULL
expressed	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

One	NULL
microgram	NULL
of	NULL
empty	NULL
vector	NULL
pLGP3	NULL
(	NULL
filled	NULL
square	NULL
)	NULL
or	NULL
increasing	NULL
amounts	NULL
of	NULL
pLGPmNFATI-C	NULL
(	NULL
open	NULL
squares	NULL
)	NULL
DNA	NULL
was	NULL
cotransfected	NULL
into	NULL
COS	NULL
cells	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
pBLCATS	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
isoform	NULL
but	NULL
also	NULL
on	NULL
the	NULL
level	NULL
of	NULL
nuclear	NULL
localization	NULL
and	NULL
appropriate	NULL
posttranslational	NULL
modification	NULL
(	NULL
55	NULL
)	NULL
.	NULL

These	NULL
functions	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
appropriately	NULL
regulated	NULL
in	NULL
COS	NULL
cells	NULL
:	NULL
as	NULL
reported	NULL
for	NULL
NFAT3	NULL
(	NULL
18	NULL
)	NULL
,	NULL
transactivation	NULL
by	NULL
NFAT1	NULL
in	NULL
COS	NULL
cells	NULL
was	NULL
not	NULL
altered	NULL
by	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
recombinant	NULL
NFAT1	NULL
was	NULL
found	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
transfected	NULL
COS	NULL
cells	NULL
and	NULL
to	NULL
some	NULL
extent	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
some	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

Neither	NULL
the	NULL
subcellular	NULL
distribution	NULL
of	NULL
the	NULL
NFAT1	NULL
nor	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
containing	NULL
NFAT1	NULL
in	NULL
their	NULL
nuclei	NULL
was	NULL
detectably	NULL
altered	NULL
by	NULL
ionomycin	NULL
stimulation	NULL
,	NULL
suggesting	NULL
that	NULL
NFAT1	NULL
is	NULL
not	NULL
regulated	NULL
by	NULL
a	NULL
calcium-stimulated	NULL
signaling	NULL
pathway	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

Although	NULL
COS	NULL
cells	NULL
have	NULL
been	NULL
widely	NULL
used	NULL
in	NULL
studying	NULL
transactivation	NULL
by	NULL
recombinant	NULL
NFAT	NULL
family	NULL
proteins	NULL
(	NULL
17	NULL
,	NULL
18	NULL
,	NULL
28	NULL
,	NULL
41	NULL
)	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
COS	NULL
cells	NULL
lack	NULL
the	NULL
requisite	NULL
mechanisms	NULL
for	NULL
regulating	NULL
NFAT1	NULL
subcellular	NULL
localization	NULL
and	NULL
transactivation	NULL
.	NULL

Transactivation	NULL
and	NULL
regulation	NULL
of	NULL
NFAT1	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
transactivation	NULL
activity	NULL
of	NULL
NFAT1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
show	NULL
calcium-	NULL
and	NULL
calcineurin-dependent	NULL
regulation	NULL
of	NULL
the	NULL
endogenous	NULL
cytoplasmic	NULL
component	NULL
of	NULL
NFAT	NULL
(	NULL
7	NULL
,	NULL
30	NULL
,	NULL
65	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
NFAT1	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
resulted	NULL
in	NULL
increased	NULL
expression	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
NFAT	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

This	NULL
small	NULL
increase	NULL
in	NULL
basal	NULL
transactivation	NULL
activity	NULL
is	NULL
most	NULL
likely	NULL
due	NULL
to	NULL
some	NULL
spillover	NULL
of	NULL
the	NULL
overexpressed	NULL
NFAT1	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
since	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
recombinant	NULL
NFAT1	NULL
is	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NFAT1	NULL
is	NULL
inducible	NULL
:	NULL
stimulation	NULL
of	NULL
the	NULL
NFAT1-transfected	NULL
cells	NULL
with	NULL
ionomycin	NULL
plus	NULL
PMA	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
by	NULL
6-	NULL
to	NULL
30-fold	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
;	NULL
compare	NULL
lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7	NULL
with	NULL
lanes	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
upon	NULL
stimulation	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
vector	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
can	NULL
be	NULL
attributed	NULL
to	NULL
endogenous	NULL
NFAT	NULL
.	NULL

However	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
NFAT-dependent	NULL
transactivation	NULL
mediated	NULL
by	NULL
overexpressed	NULL
recombinant	NULL
NFAT1	NULL
is	NULL
sufficiently	NULL
large	NULL
by	NULL
comparison	NULL
that	NULL
we	NULL
were	NULL
able	NULL
to	NULL
investigate	NULL
the	NULL
regulation	NULL
of	NULL
NFAT1	NULL
in	NULL
Jurkat	NULL
cells	NULL
independently	NULL
of	NULL
the	NULL
endogenous	NULL
NFAT	NULL
family	NULL
proteins	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

To	NULL
further	NULL
study	NULL
the	NULL
regulation	NULL
of	NULL
recombinant	NULL
NFAT1	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
individual	NULL
effects	NULL
of	NULL
ionomycin	NULL
and	NULL
PMA	NULL
on	NULL
transactivation	NULL
by	NULL
NFATI-C	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Ionomycin	NULL
or	NULL
PMA	NULL
alone	NULL
did	NULL
not	NULL
stimulate	NULL
detectable	NULL
endogenous	NULL
NFAT	NULL
transactivation	NULL
activity	NULL
,	NULL
but	NULL
together	NULL
they	NULL
did	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
.	NULL

Tonomycin	NULL
alone	NULL
reproducibly	NULL
stimulated	NULL
transactivation	NULL
mediated	NULL
by	NULL
the	NULL
recombinant	NULL
NFAT1	NULL
by	NULL
two-	NULL
to	NULL
threefold	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
whereas	NULL
PMA	NULL
alone	NULL
caused	NULL
only	NULL
a	NULL
marginal	NULL
increase	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Ionomycin	NULL
plus	NULL
PMA	NULL
gave	NULL
maximal	NULL
stimulation	NULL
of	NULL
the	NULL
NFAT	NULL
activity	NULL
by	NULL
10-	NULL
to	NULL
30-fold	NULL
over	NULL
that	NULL
of	NULL
the	NULL
unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
stimulation	NULL
of	NULL
NFAT1	NULL
activity	NULL
by	NULL
ionomycin	NULL
was	NULL
blocked	NULL
by	NULL
pretreatment	NULL
of	NULL
cells	NULL
with	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

The	NULL
recombinant	NULL
NFAT1	NULL
was	NULL
present	NULL
at	NULL
equivalent	NULL
levels	NULL
under	NULL
all	NULL
conditions	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
NFAT	NULL
site	NULL
that	NULL
we	NULL
used	NULL
is	NULL
a	NULL
composite	NULL
site	NULL
con	NULL
NFAT3X	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
transfected	NULL
was	NULL
kept	NULL
constant	NULL
at	NULL
1	NULL
pg	NULL
per	NULL
transfection	NULL
by	NULL
using	NULL
the	NULL
empty	NULL
vector	NULL
DNA	NULL
.	NULL

Two	NULL
days	NULL
after	NULL
transfection	NULL
,	NULL
half	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
for	NULL
Western	NULL
analysis	NULL
(	NULL
insert	NULL
)	NULL
as	NULL
in	NULL
panel	NULL
A	NULL
,	NULL
and	NULL
half	NULL
were	NULL
used	NULL
for	NULL
CAT	NULL
assays	NULL
as	NULL
in	NULL
panel	NULL
B	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Subcellular	NULL
distribution	NULL
of	NULL
NFAT1	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
as	NULL
in	NULL
panel	NULL
A	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
pEFTAG	NULL
mNFAT1-C	NULL
plasmid	NULL
;	NULL
1	NULL
day	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
transferred	NULL
to	NULL
coverslips	NULL
and	NULL
grown	NULL
overnight	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
5	NULL
mM	NULL
ionomycin	NULL
for	NULL
20	NULL
min	NULL
and	NULL
then	NULL
fixed	NULL
for	NULL
immunocytochemistry	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
transfection	NULL
experiments	NULL
.	NULL

Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
A	NULL
Reporter	NULL
:	NULL
pBLCATS/NFAT3X	NULL
vector	NULL
NFAT1-A	NULL
NFAT1-B	NULL
NFAT1-C	NULL
P+l	NULL
>	NULL
-	NULL
+	NULL
=	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
a	NULL
@	NULL
C	NULL
Reporter	NULL
:	NULL
pBLCATS/NFAT3X	NULL
P+l	NULL
-	NULL
+	NULL
+	NULL
CsA	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
%	NULL
conv	NULL
.	NULL

1.5	NULL
-	NULL
7.9	NULL
1.6	NULL
1.1	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Transactivation	NULL
by	NULL
NFAT1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Transactivation	NULL
by	NULL
NFAT1	NULL
isoforms	NULL
in	NULL
resting	NULL
(	NULL
-	NULL
)	NULL
and	NULL
stimulated	NULL
(	NULL
+	NULL
)	NULL
Jurkat	NULL
cells	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
pBLCATS/NFAT3X	NULL
reporter	NULL
plasmid	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
pLGP3	NULL
empty	NULL
vector	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
pLGPmNFAT1-A	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
pLGPmNFAT1-B	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
or	NULL
pLGPmNFAT1-C	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
and	NULL
each	NULL
transfection	NULL
mixture	NULL
was	NULL
aliquoted	NULL
into	NULL
two	NULL
flasks	NULL
.	NULL

One	NULL
day	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7	NULL
)	NULL
or	NULL
treated	NULL
overnight	NULL
with	NULL
1	NULL
uM	NULL
ionomycin	NULL
(	NULL
I	NULL
)	NULL
and	NULL
10	NULL
nM	NULL
PMA	NULL
(	NULL
P	NULL
)	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
in	NULL
cell	NULL
extracts	NULL
was	NULL
assayed	NULL
the	NULL
next	NULL
day	NULL
and	NULL
is	NULL
shown	NULL
as	NULL
percent	NULL
conversion	NULL
under	NULL
each	NULL
lane	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transactivation	NULL
by	NULL
NFAT1	NULL
in	NULL
response	NULL
to	NULL
different	NULL
stimuli	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
pBLCATS/NFAT3X	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
pEFTAG	NULL
(	NULL
lane	NULL
1	NULL
to	NULL
4	NULL
)	NULL
or	NULL
10	NULL
pg	NULL
of	NULL
pEFTAGmNFAT1-C	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
,	NULL
and	NULL
each	NULL
transfection	NULL
mixture	NULL
was	NULL
aliquoted	NULL
into	NULL
four	NULL
flasks	NULL
.	NULL

One	NULL
day	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
overnight	NULL
with	NULL
1	NULL
M	NULL
ionomycin	NULL
(	NULL
I	NULL
)	NULL
,	NULL
10	NULL
nM	NULL
PMA	NULL
(	NULL
P	NULL
)	NULL
,	NULL
or	NULL
both	NULL
(	NULL
P+1	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
in	NULL
cell	NULL
extracts	NULL
was	NULL
assayed	NULL
the	NULL
next	NULL
day	NULL
.	NULL

The	NULL
percent	NULL
conversion	NULL
normalized	NULL
for	NULL
total	NULL
protein	NULL
amount	NULL
in	NULL
each	NULL
sample	NULL
is	NULL
shown	NULL
under	NULL
each	NULL
lane	NULL
.	NULL

(	NULL
C	NULL
)	NULL
CsA	NULL
inhibits	NULL
NFAT1	NULL
transactivation	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
pBLCATS/NFAT3X	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
pEFTAG	NULL
mNFAT1-C	NULL
as	NULL
in	NULL
panel	NULL
B	NULL
and	NULL
aliquoted	NULL
into	NULL
four	NULL
flasks	NULL
.	NULL

One	NULL
day	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
CsA	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
either	NULL
unstimulated	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
overnight	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
(	NULL
P+1	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
in	NULL
panel	NULL
B	NULL
.	NULL

Data	NULL
in	NULL
all	NULL
panels	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

taining	NULL
both	NULL
NFAT1	NULL
and	NULL
AP-1-binding	NULL
sites	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
47	NULL
)	NULL
.	NULL

The	NULL
dual	NULL
requirement	NULL
for	NULL
ionomycin	NULL
and	NULL
PMA	NULL
stimulation	NULL
suggests	NULL
that	NULL
transactivation	NULL
from	NULL
this	NULL
site	NULL
is	NULL
a	NULL
result	NULL
of	NULL
cooperation	NULL
of	NULL
NFAT1	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
(	NULL
4	NULL
,	NULL
21	NULL
,	NULL
47	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
activation	NULL
of	NULL
recombinant	NULL
NFAT1	NULL
accurately	NULL
represents	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
component	NULL
of	NULL
NFAT	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

REGULATION	NULL
OF	NULL
RECOMBINANT	NULL
NFAT1I	NULL
3961	NULL
Stimulation	NULL
of	NULL
NFAT1-mediated	NULL
transactivation	NULL
activity	NULL
by	NULL
calcineurin	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
CsA	NULL
to	NULL
inhibit	NULL
transactivation	NULL
mediated	NULL
by	NULL
NFAT1	NULL
indicated	NULL
that	NULL
recombinant	NULL
NFAT1	NULL
is	NULL
regulated	NULL
by	NULL
calcineurin	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
this	NULL
hypothesis	NULL
further	NULL
,	NULL
we	NULL
transiently	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
with	NULL
expression	NULL
plasmids	NULL
encoding	NULL
NFAT1	NULL
,	NULL
a	NULL
constitutively	NULL
active	NULL
form	NULL
of	NULL
the	NULL
calcineurin	NULL
A	NULL
chain	NULL
lacking	NULL
its	NULL
autoinhibitory	NULL
domain	NULL
,	NULL
the	NULL
calcineurin	NULL
B	NULL
chain	NULL
,	NULL
and	NULL
the	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

We	NULL
included	NULL
the	NULL
calcineurin	NULL
B	NULL
chain	NULL
in	NULL
the	NULL
experiments	NULL
because	NULL
it	NULL
is	NULL
required	NULL
for	NULL
the	NULL
stability	NULL
and	NULL
catalytic	NULL
activity	NULL
of	NULL
the	NULL
calcineurin	NULL
A	NULL
chain	NULL
,	NULL
whether	NULL
full	NULL
length	NULL
or	NULL
truncated	NULL
to	NULL
remove	NULL
the	NULL
autoinhibitory	NULL
domain	NULL
(	NULL
34	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
calcineurin	NULL
stimulated	NULL
CAT	NULL
expression	NULL
,	NULL
presumably	NULL
by	NULL
activating	NULL
endogenous	NULL
NFAT	NULL
,	NULL
and	NULL
CAT	NULL
levels	NULL
were	NULL
further	NULL
increased	NULL
by	NULL
treatment	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
over-expressing	NULL
NFAT1	NULL
,	NULL
active	NULL
calcineurin	NULL
strongly	NULL
increased	NULL
CAT	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
stimulation	NULL
,	NULL
and	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
further	NULL
enhanced	NULL
transactivation	NULL
.	NULL

Treatment	NULL
with	NULL
CsA	NULL
blocked	NULL
both	NULL
the	NULL
effect	NULL
of	NULL
calcineurin	NULL
and	NULL
the	NULL
stimulation	NULL
by	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

These	NULL
experiments	NULL
strengthen	NULL
the	NULL
conclusion	NULL
that	NULL
activation	NULL
of	NULL
recombinant	NULL
NFAT1	NULL
is	NULL
controlled	NULL
by	NULL
calcineurin	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
recombinant	NULL
NFAT1	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
recombinant	NULL
NFAT1	NULL
by	NULL
immunocytochemistry	NULL
.	NULL

A	NULL
plasmid	NULL
encoding	NULL
full-length	NULL
HA-tagged	NULL
murine	NULL
NFAT1	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
epitope	NULL
tag	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
change	NULL
the	NULL
transactivation	NULL
activity	NULL
of	NULL
the	NULL
recombinant	NULL
NFAT1	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
and	NULL
the	NULL
transactivation	NULL
activity	NULL
of	NULL
the	NULL
tagged	NULL
recombinant	NULL
NFAT1	NULL
was	NULL
enhanced	NULL
by	NULL
the	NULL
constitutively	NULL
active	NULL
calcineurin	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
recombinant	NULL
NFAT1	NULL
protein	NULL
was	NULL
visualized	NULL
by	NULL
using	NULL
monoclonal	NULL
antibody	NULL
12CAS	NULL
against	NULL
the	NULL
HA	NULL
epitope	NULL
,	NULL
and	NULL
the	NULL
nuclei	NULL
of	NULL
Jurkat	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
Hoechst	NULL
dye	NULL
33342	NULL
.	NULL

In	NULL
resting	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
recombinant	NULL
NFAT1	NULL
was	NULL
cytoplasmic	NULL
,	NULL
with	NULL
minimal	NULL
antibody	NULL
staining	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
different	NULL
staining	NULL
patterns	NULL
of	NULL
antibody	NULL
12CA5	NULL
and	NULL
Hoechst	NULL
dye	NULL
33342	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
top	NULL
panels	NULL
)	NULL
.	NULL

Ionomycin	NULL
stimulation	NULL
caused	NULL
translocation	NULL
of	NULL
HA-tagged	NULL
NFAT1	NULL
into	NULL
the	NULL
nucleus	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
transfected	NULL
cells	NULL
,	NULL
as	NULL
visualized	NULL
by	NULL
the	NULL
overlapping	NULL
staining	NULL
of	NULL
12CAS	NULL
and	NULL
Hoechst	NULL
dye	NULL
in	NULL
the	NULL
center	NULL
of	NULL
the	NULL
cells	NULL
(	NULL
center	NULL
panels	NULL
)	NULL
,	NULL
and	NULL
this	NULL
translocation	NULL
was	NULL
completely	NULL
blocked	NULL
by	NULL
pretreatment	NULL
of	NULL
the	NULL
50	NULL
[	NULL
]	NULL
Unstim	NULL
40	NULL
2	NULL
6	NULL
P+	NULL
>	NULL
0	NULL
30	NULL
CsA	NULL
C	NULL
20	NULL
L—t	NULL
|	NULL
§	NULL
P+	NULL
!	NULL

1+CsA	NULL
O	NULL
107	NULL
o	NULL
-	NULL
CBRL	NULL
__	NULL
_-	NULL
I	NULL
[	NULL
-£	NULL
]	NULL
endog	NULL
endog	NULL
NFAT1i	NULL
NFAT	NULL
+	NULL
+	NULL
CaN	NULL
CaN	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Calcineurin	NULL
increases	NULL
transactivation	NULL
mediated	NULL
by	NULL
NFAT1	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
pBLCATS5/NFAT3X	NULL
reporter	NULL
and	NULL
empty	NULL
expression	NULL
vectors	NULL
(	NULL
endog	NULL
)	NULL
,	NULL
10	NULL
ug	NULL
each	NULL
of	NULL
pSRa-ACaM-AI	NULL
and	NULL
pSR	NULL
«	NULL
-CnB	NULL
(	NULL
endog	NULL
+	NULL
CaN	NULL
)	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
pEFTAGmNFATI1-C	NULL
(	NULL
NFAT1	NULL
)	NULL
,	NULL
or	NULL
10	NULL
pg	NULL
each	NULL
of	NULL
pEFTAGmFNAT1-C	NULL
,	NULL
pSRa-ACaM-ALI	NULL
,	NULL
and	NULL
pSRe-CnB	NULL
(	NULL
NFAT1	NULL
+	NULL
CaN	NULL
)	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
per	NULL
transfection	NULL
was	NULL
kept	NULL
constant	NULL
by	NULL
using	NULL
appropriate	NULL
empty	NULL
vectors	NULL
.	NULL

Each	NULL
transfection	NULL
mixture	NULL
was	NULL
aliquoted	NULL
into	NULL
four	NULL
flasks	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
the	NULL
next	NULL
day	NULL
as	NULL
indicated	NULL
.	NULL

For	NULL
CsA	NULL
treatment	NULL
,	NULL
CsA	NULL
was	NULL
added	NULL
to	NULL
cell	NULL
culture	NULL
media	NULL
immediately	NULL
after	NULL
transfection	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
M.	NULL
Bars	NULL
represent	NULL
CAT	NULL
activity	NULL
in	NULL
percent	NULL
conversion	NULL
measured	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

Unstim	NULL
,	NULL
unstimu-lated	NULL
;	NULL
P	NULL
+	NULL
I	NULL
,	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

3962	NULL
LUO	NULL
ET	NULL
AL	NULL
.	NULL

Phase	NULL
Unstimulated	NULL
lonomycin	NULL
CsA+lonomycin	NULL
12CA5	NULL
©	NULL
ky	NULL
,	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Hoechst	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Regulation	NULL
of	NULL
subcellular	NULL
localization	NULL
of	NULL
NFAT1	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
pEFTAGmNFAT1-C	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Two	NULL
days	NULL
after	NULL
transfection	NULL
,	NULL
recombinant	NULL
NFAT1	NULL
was	NULL
visualized	NULL
with	NULL
antibody	NULL
12CA5	NULL
to	NULL
the	NULL
HA	NULL
tag	NULL
(	NULL
12CA3	NULL
)	NULL
,	NULL
and	NULL
the	NULL
nuclei	NULL
were	NULL
stained	NULL
with	NULL
Hoechst	NULL
dye	NULL
33342	NULL
(	NULL
Hoechst	NULL
)	NULL
.	NULL

Routinely	NULL
,	NULL
transfection	NULL
efficiency	NULL
was	NULL
1	NULL
to	NULL
5	NULL
%	NULL
,	NULL
as	NULL
estimated	NULL
from	NULL
the	NULL
total	NULL
number	NULL
of	NULL
cells	NULL
stained	NULL
.	NULL

Untransfected	NULL
cells	NULL
are	NULL
visible	NULL
by	NULL
phase-contrast	NULL
microscopy	NULL
(	NULL
Phase	NULL
)	NULL
and	NULL
with	NULL
Hoechst	NULL
staining	NULL
but	NULL
are	NULL
invisible	NULL
with	NULL
12CA5	NULL
staining	NULL
.	NULL

Shown	NULL
are	NULL
representative	NULL
fields	NULL
(	NULL
magnification	NULL
,	NULL
X100	NULL
)	NULL
of	NULL
cells	NULL
left	NULL
unstimulated	NULL
(	NULL
Unstimulated	NULL
)	NULL
,	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
for	NULL
15	NULL
min	NULL
(	NULL
Ionomycin	NULL
)	NULL
,	NULL
or	NULL
CsA	NULL
treated	NULL
and	NULL
then	NULL
ionomycin	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
(	NULL
CsA	NULL
The	NULL
condition	NULL
of	NULL
cells	NULL
was	NULL
checked	NULL
under	NULL
phase-contrast	NULL
field	NULL
(	NULL
Phase	NULL
)	NULL
.	NULL

cells	NULL
with	NULL
CsA	NULL
(	NULL
bottom	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
same	NULL
results	NULL
were	NULL
observed	NULL
in	NULL
murine	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
same	NULL
plasmid	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
same	NULL
subcellular	NULL
distribution	NULL
was	NULL
observed	NULL
for	NULL
recombinant	NULL
NFAT1	NULL
without	NULL
the	NULL
HA	NULL
tag	NULL
,	NULL
which	NULL
can	NULL
be	NULL
visualized	NULL
by	NULL
using	NULL
antibodies	NULL
directed	NULL
against	NULL
NFAT1	NULL
in	NULL
transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
because	NULL
of	NULL
the	NULL
low	NULL
level	NULL
of	NULL
endogenous	NULL
NFAT1	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
,	NULL
which	NULL
have	NULL
been	NULL
reproduced	NULL
in	NULL
two	NULL
different	NULL
Jurkat	NULL
cell	NULL
lines	NULL
,	NULL
confirm	NULL
that	NULL
the	NULL
subcellular	NULL
distribution	NULL
of	NULL
recombinant	NULL
NFAT1	NULL
in	NULL
Jurkat	NULL
cells	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
calcium-	NULL
and	NULL
calcineurin-dependent	NULL
pathway	NULL
,	NULL
as	NULL
observed	NULL
for	NULL
endogenous	NULL
NFAT1	NULL
in	NULL
murine	NULL
T	NULL
cells	NULL
and	NULL
primary	NULL
lymphoid	NULL
cells	NULL
(	NULL
51	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Transactivation	NULL
mediated	NULL
by	NULL
NFAT1	NULL
at	NULL
different	NULL
cytokine	NULL
gene	NULL
promoters	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
NFAT1	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
different	NULL
cytokine	NULL
genes	NULL
by	NULL
cotransfecting	NULL
Jurkat	NULL
cells	NULL
with	NULL
an	NULL
NFAT1-expressing	NULL
plasmid	NULL
and	NULL
reporter	NULL
plasmids	NULL
in	NULL
which	NULL
expression	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
was	NULL
controlled	NULL
by	NULL
the	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
or	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
was	NULL
detected	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
plus	NULL
PMA	NULL
but	NULL
not	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
and	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
NFAT1	NULL
expression	NULL
plasmid	NULL
showed	NULL
a	NULL
much	NULL
higher	NULL
level	NULL
of	NULL
inducible	NULL
CAT	NULL
expression	NULL
than	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
induction	NULL
of	NULL
CAT	NULL
gene	NULL
expression	NULL
was	NULL
blocked	NULL
by	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
hGH	NULL
controlled	NULL
by	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
promoter	NULL
was	NULL
not	NULL
influenced	NULL
by	NULL
coexpression	NULL
of	NULL
NFAT1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
these	NULL
results	NULL
ruled	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
induction	NULL
of	NULL
IL-2	NULL
promoter	NULL
was	NULL
due	NULL
to	NULL
gross	NULL
increase	NULL
in	NULL
transcription	NULL
by	NULL
NFAT1	NULL
.	NULL

Similarly	NULL
,	NULL
overexpression	NULL
of	NULL
NFAT1	NULL
increased	NULL
transcription	NULL
driven	NULL
by	NULL
the	NULL
promoters	NULL
of	NULL
murine	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
,	NULL
human	NULL
TNF-	NULL
«	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
)	NULL
,	NULL
and	NULL
human	NULL
GM-CSF	NULL
(	NULL
Fig	NULL
.	NULL

8D	NULL
)	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
plus	NULL
PMA	NULL
.	NULL

These	NULL
results	NULL
have	NULL
been	NULL
seen	NULL
in	NULL
multiple	NULL
transfection	NULL
experiments	NULL
using	NULL
different	NULL
plasmid	NULL
preparations	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

They	NULL
demonstrate	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
recombinant	NULL
NFAT1	NULL
is	NULL
capable	NULL
of	NULL
contributing	NULL
to	NULL
inducible	NULL
transcription	NULL
from	NULL
several	NULL
cytokine	NULL
promoters	NULL
,	NULL
suggesting	NULL
that	NULL
NFAT1	NULL
participates	NULL
in	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
many	NULL
different	NULL
cytokines	NULL
during	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
isolated	NULL
two	NULL
new	NULL
isoforms	NULL
of	NULL
NFAT1	NULL
that	NULL
are	NULL
the	NULL
predominant	NULL
isoforms	NULL
present	NULL
in	NULL
immune	NULL
system	NULL
cells	NULL
.	NULL

When	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
these	NULL
proteins	NULL
(	NULL
NFAT1-B	NULL
and	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
A	NULL
IL-2	NULL
B	NULL
IL-4	NULL
40	NULL
-	NULL
10	NULL
>	NULL
30-7	NULL
3	NULL
7.54	NULL
S	NULL
>	NULL
E	NULL
20	NULL
-	NULL
I	NULL
5	NULL
--	NULL
let	NULL
-	NULL
2.5	NULL
5	NULL
10	NULL
g	NULL
o	NULL
-	NULL
=	NULL
proven	NULL
braze	NULL
o-	NULL
C4	NULL
-z	NULL
g	NULL
oy	NULL
5	NULL
_-	NULL
$	NULL
P	NULL
§	NULL
Z	NULL
f	NULL
€	NULL
P	NULL
$	NULL
i	NULL
5	NULL
5	NULL
4	NULL
[	NULL
<	NULL
2	NULL
0	NULL
3	NULL
3	NULL
Vector	NULL
NFAT1	NULL
Vector	NULL
NFAT	NULL
C	NULL
TNF-a	NULL
D	NULL
GM-CSF	NULL
>	NULL
15-	NULL
80	NULL
'	NULL
>	NULL
=	NULL
>	NULL
60	NULL
{	NULL
10	NULL
-	NULL
g	NULL
o	NULL
3	NULL
-|	NULL
g	NULL
s	NULL
3	NULL
40	NULL
£	NULL
a	NULL
20	NULL
o	NULL
O	NULL
3	NULL
-_	NULL
o-	NULL
e	NULL
}	NULL
o	NULL
-	NULL
Frm	NULL
__	NULL
&	NULL
f	NULL
&	NULL
iI	NULL
£2	NULL
§	NULL
I	NULL
a	NULL
%	NULL
6	NULL
6	NULL
£	NULL
<	NULL
[	NULL
<	NULL
[	NULL
=	NULL
3	NULL
3	NULL
3	NULL
3	NULL
Vector	NULL
NFAT	NULL
Vector	NULL
NFAT	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

NFAT1	NULL
transactivates	NULL
the	NULL
IL-2	NULL
(	NULL
A	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
B	NULL
)	NULL
,	NULL
TNF-	NULL
«	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
GM-CSF	NULL
(	NULL
D	NULL
)	NULL
promoters	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
2	NULL
pg	NULL
of	NULL
5'IL2-CAT	NULL
reporter	NULL
plasmid	NULL
(	NULL
A	NULL
)	NULL
or	NULL
5	NULL
ag	NULL
of	NULL
pSVO-801	NULL
(	NULL
B	NULL
)	NULL
,	NULL
TNFa-Luc	NULL
(	NULL
C	NULL
)	NULL
,	NULL
or	NULL
pHGM	NULL
(	NULL
D	NULL
)	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
an	NULL
NFAT1	NULL
expression	NULL
vector	NULL
(	NULL
NFAT1	NULL
)	NULL
or	NULL
an	NULL
empty	NULL
vector	NULL
control	NULL
(	NULL
vector	NULL
)	NULL
and	NULL
then	NULL
aliquoted	NULL
into	NULL
three	NULL
or	NULL
two	NULL
flasks	NULL
.	NULL

One	NULL
day	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
Unstim	NULL
)	NULL
,	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
P+1	NULL
)	NULL
,	NULL
or	NULL
pretreated	NULL
with	NULL
1	NULL
M	NULL
CsA	NULL
for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
stimulated	NULL
overnight	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
CsA+P+1	NULL
)	NULL
.	NULL

Bars	NULL
depict	NULL
CAT	NULL
activity	NULL
(	NULL
in	NULL
percent	NULL
conver-sion	NULL
)	NULL
or	NULL
luciferase	NULL
(	NULL
in	NULL
10°	NULL
light	NULL
units	NULL
)	NULL
activity	NULL
measured	NULL
1	NULL
day	NULL
after	NULL
stimulation	NULL
.	NULL

The	NULL
transfection	NULL
efficiency	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
the	NULL
hGH	NULL
expression	NULL
from	NULL
a	NULL
cotransfected	NULL
Rous	NULL
sarcoma	NULL
virus-hGH	NULL
plasmid	NULL
.	NULL

NFAT1-C	NULL
)	NULL
exhibit	NULL
the	NULL
properties	NULL
expected	NULL
for	NULL
the	NULL
cytoplasmic	NULL
component	NULL
of	NULL
NFAT	NULL
.	NULL

Like	NULL
endogenous	NULL
NFAT1	NULL
(	NULL
55	NULL
)	NULL
,	NULL
the	NULL
recombinant	NULL
proteins	NULL
localize	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
resting	NULL
cells	NULL
and	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
upon	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
however	NULL
(	NULL
30	NULL
)	NULL
,	NULL
their	NULL
full	NULL
transcriptional	NULL
activity	NULL
at	NULL
multimerized	NULL
NFAT	NULL
sites	NULL
requires	NULL
additional	NULL
stimulation	NULL
with	NULL
PMA	NULL
.	NULL

Transactivation	NULL
mediated	NULL
by	NULL
recombinant	NULL
NFAT	NULL
1	NULL
is	NULL
potentiated	NULL
by	NULL
coexpression	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
form	NULL
of	NULL
calcineurin	NULL
,	NULL
as	NULL
previously	NULL
noted	NULL
for	NULL
transactivation	NULL
by	NULL
endogenous	NULL
NFAT	NULL
(	NULL
7	NULL
,	NULL
15	NULL
,	NULL
25	NULL
,	NULL
62	NULL
,	NULL
65	NULL
)	NULL
.	NULL

Recombinant	NULL
NFAT1	NULL
increased	NULL
transcription	NULL
of	NULL
several	NULL
cytokine	NULL
promoters	NULL
(	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
)	NULL
previously	NULL
shown	NULL
to	NULL
possess	NULL
NFAT-binding	NULL
sites	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
47	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
NFAT1	NULL
contributes	NULL
to	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
these	NULL
cytokine	NULL
genes	NULL
,	NULL
and	NULL
possibly	NULL
other	NULL
CsA-sensitive	NULL
genes	NULL
,	NULL
during	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

However	NULL
,	NULL
NFAT1	NULL
may	NULL
not	NULL
be	NULL
absolutely	NULL
required	NULL
or	NULL
may	NULL
be	NULL
compensated	NULL
by	NULL
other	NULL
NFAT	NULL
family	NULL
proteins	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
cytokines	NULL
,	NULL
since	NULL
the	NULL
levels	NULL
of	NULL
IL-2	NULL
and	NULL
TNF-a	NULL
produced	NULL
by	NULL
T	NULL
cells	NULL
of	NULL
NFAT1-deficient	NULL
mice	NULL
appear	NULL
normal	NULL
(	NULL
172	NULL
,	NULL
66	NULL
)	NULL
.	NULL

A	NULL
previous	NULL
report	NULL
showed	NULL
that	NULL
after	NULL
subcellular	NULL
fraction-ation	NULL
of	NULL
resting	NULL
Jurkat	NULL
and	NULL
Raji	NULL
cell	NULL
lines	NULL
,	NULL
NFAT1	NULL
was	NULL
present	NULL
in	NULL
both	NULL
the	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
fractions	NULL
and	NULL
its	NULL
subcellular	NULL
distribution	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
CsA	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
the	NULL
apparent	NULL
constitutive	NULL
nuclear	NULL
localization	NULL
of	NULL
NFAT1	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
is	NULL
not	NULL
clear	NULL
;	NULL
although	NULL
the	NULL
authors	NULL
showed	NULL
that	NULL
their	NULL
nuclear	NULL
extracts	NULL
were	NULL
not	NULL
contami-	NULL
REGULATION	NULL
OF	NULL
RECOMBINANT	NULL
NFAT1I	NULL
3963	NULL
nated	NULL
with	NULL
an	NULL
abundant	NULL
cytoplasmic	NULL
protein	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
their	NULL
lysis	NULL
and	NULL
extraction	NULL
conditions	NULL
permitted	NULL
cytoplasmic	NULL
to	NULL
nuclear	NULL
redistribution	NULL
of	NULL
NFAT1	NULL
.	NULL

Alternatively	NULL
,	NULL
cell	NULL
culture	NULL
conditions	NULL
may	NULL
have	NULL
resulted	NULL
in	NULL
partial	NULL
nuclear	NULL
localization	NULL
of	NULL
NFAT1	NULL
,	NULL
or	NULL
the	NULL
cell	NULL
lines	NULL
used	NULL
may	NULL
have	NULL
had	NULL
specific	NULL
alterations	NULL
in	NULL
the	NULL
NFAT	NULL
activation	NULL
pathway	NULL
.	NULL

A	NULL
precedent	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
murine	NULL
lymphoma	NULL
ELA	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
has	NULL
a	NULL
high	NULL
constitutive	NULL
level	NULL
of	NULL
nuclear	NULL
NFAT	NULL
and	NULL
harbors	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
calcineurin	NULL
Aa	NULL
chain	NULL
that	NULL
results	NULL
in	NULL
constitutive	NULL
calcineurin	NULL
phosphatase	NULL
activity	NULL
(	NULL
12	NULL
)	NULL
.	NULL

These	NULL
questions	NULL
could	NULL
be	NULL
resolved	NULL
by	NULL
immunocytochemical	NULL
analysis	NULL
of	NULL
NFAT1	NULL
localization	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
.	NULL

Nevertheless	NULL
,	NULL
these	NULL
cells	NULL
have	NULL
been	NULL
valuable	NULL
for	NULL
establishing	NULL
a	NULL
second	NULL
important	NULL
mechanism	NULL
by	NULL
which	NULL
calcineurin	NULL
regulates	NULL
NFAT1	NULL
function	NULL
,	NULL
namely	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
DNA-binding	NULL
activity	NULL
following	NULL
dephosphorylation	NULL
(	NULL
44	NULL
)	NULL
.	NULL

This	NULL
mechanism	NULL
has	NULL
also	NULL
been	NULL
borne	NULL
out	NULL
in	NULL
the	NULL
untransformed	NULL
murine	NULL
T-cell	NULL
clone	NULL
Ar-5	NULL
(	NULL
55	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
Jurkat	NULL
lines	NULL
used	NULL
in	NULL
this	NULL
study	NULL
(	NULL
27a	NULL
)	NULL
.	NULL

NFAT1	NULL
possesses	NULL
two	NULL
regions	NULL
of	NULL
sequence	NULL
similarity	NULL
with	NULL
the	NULL
other	NULL
three	NULL
NFAT	NULL
family	NULL
proteins	NULL
and	NULL
two	NULL
regions	NULL
of	NULL
unique	NULL
sequence	NULL
.	NULL

The	NULL
283-aa	NULL
DNA-binding	NULL
domain	NULL
of	NULL
NFAT1	NULL
is	NULL
highly	NULL
conserved	NULL
(	NULL
66	NULL
to	NULL
72	NULL
%	NULL
sequence	NULL
identity	NULL
)	NULL
with	NULL
the	NULL
other	NULL
NFAT	NULL
family	NULL
proteins	NULL
(	NULL
18	NULL
,	NULL
28	NULL
,	NULL
41	NULL
)	NULL
.	NULL

A	NULL
novel	NULL
NHR	NULL
just	NULL
N	NULL
terminal	NULL
to	NULL
the	NULL
DNA-binding	NULL
domain	NULL
also	NULL
shows	NULL
significant	NULL
conservation	NULL
of	NULL
sequence	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
N-terminal	NULL
~100	NULL
aa	NULL
is	NULL
unique	NULL
in	NULL
each	NULL
NFAT	NULL
family	NULL
protein	NULL
;	NULL
it	NULL
is	NULL
rich	NULL
in	NULL
acidic	NULL
residues	NULL
and	NULL
proline	NULL
in	NULL
the	NULL
case	NULL
of	NULL
NFAT1	NULL
,	NULL
NFAT3	NULL
,	NULL
and	NULL
NFATA4/NFAT	NULL
'	NULL
x	NULL
and	NULL
is	NULL
proline	NULL
rich	NULL
but	NULL
not	NULL
especially	NULL
acidic	NULL
in	NULL
the	NULL
case	NULL
of	NULL
NFATe	NULL
(	NULL
18	NULL
,	NULL
28	NULL
,	NULL
41	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
region	NULL
immediately	NULL
C	NULL
terminal	NULL
to	NULL
the	NULL
DNA-binding	NULL
domain	NULL
,	NULL
when	NULL
present	NULL
,	NULL
is	NULL
also	NULL
unique	NULL
to	NULL
each	NULL
NFAT	NULL
family	NULL
protein	NULL
(	NULL
18	NULL
,	NULL
28	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
functions	NULL
of	NULL
these	NULL
unique	NULL
and	NULL
conserved	NULL
regions	NULL
(	NULL
other	NULL
than	NULL
the	NULL
DNA-binding	NULL
domain	NULL
)	NULL
remain	NULL
to	NULL
be	NULL
deter-mined	NULL
,	NULL
but	NULL
some	NULL
possibilities	NULL
are	NULL
discussed	NULL
below	NULL
.	NULL

As	NULL
noted	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
,	NULL
the	NULL
DNA-binding	NULL
domains	NULL
of	NULL
the	NULL
four	NULL
NFAT	NULL
family	NULL
proteins	NULL
show	NULL
a	NULL
higher	NULL
level	NULL
of	NULL
amino	NULL
acid	NULL
TABLE	NULL
1	NULL
.	NULL

Enhancement	NULL
of	NULL
the	NULL
transcription	NULL
of	NULL
cytokine	NULL
promoters	NULL
by	NULL
overexpression	NULL
of	NULL
NFAT1	NULL
in	NULL
Jurkat	NULL
cells	NULL
Relative	NULL
transactivation	NULL
activity	NULL
``	NULL
Reporter	NULL
Exp	NULL
Vector	NULL
,	NULL
___	NULL
_	NULL
Unstimulated	NULL
Unstimulated	NULL
P+I	NULL
IL-2	NULL
I	NULL
0.49	NULL
0.67	NULL
37	NULL
II	NULL
0.49	NULL
0.36	NULL
31	NULL
UP	NULL
0.14	NULL
<	NULL
0.01	NULL
28	NULL
IL-4	NULL
I	NULL
0.88	NULL
6.9	NULL
113	NULL
II	NULL
0.25	NULL
0.88	NULL
4.1	NULL
TII	NULL
<	NULL
0.01	NULL
2.8	NULL
8.8	NULL
TNF-a	NULL
I	NULL
0.11	NULL
0.18	NULL
9.4	NULL
II	NULL
0.19	NULL
0.24	NULL
8.1	NULL
TII	NULL
0.48	NULL
0.59	NULL
3.1	NULL
GM-CSF	NULL
I	NULL
0.30	NULL
0.30	NULL
11	NULL
II	NULL
0.69	NULL
0.69	NULL
2.9	NULL
TII	NULL
0.27	NULL
0.17	NULL
5.1	NULL
IV	NULL
0.44	NULL
0.39	NULL
27	NULL
``	NULL
Jurkat	NULL
cell	NULL
transfection	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
done	NULL
exactly	NULL
as	NULL
for	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Values	NULL
are	NULL
relative	NULL
CAT/luciferase	NULL
activities	NULL
normalized	NULL
to	NULL
the	NULL
CAT/luciferase	NULL
activity	NULL
of	NULL
PMA-plus-ionomycin	NULL
(	NULL
P+1	NULL
)	NULL
-stimulated	NULL
cells	NULL
transfected	NULL
with	NULL
expression	NULL
vector	NULL
and	NULL
reporter	NULL
plasmid	NULL
(	NULL
set	NULL
as	NULL
1.0	NULL
)	NULL
.	NULL

*	NULL
The	NULL
raw	NULL
data	NULL
for	NULL
CAT	NULL
or	NULL
luciferase	NULL
activity	NULL
are	NULL
plotted	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

3964	NULL
LUO	NULL
ET	NULL
AL	NULL
.	NULL

identity	NULL
in	NULL
their	NULL
N-terminal	NULL
~190	NULL
aa	NULL
than	NULL
in	NULL
their	NULL
C-terminal	NULL
portions	NULL
.	NULL

The	NULL
region	NULL
of	NULL
high	NULL
sequence	NULL
similarity	NULL
corresponds	NULL
to	NULL
the	NULL
minimal	NULL
DNA-binding	NULL
subdomain	NULL
of	NULL
NFAT1	NULL
(	NULL
187	NULL
aa	NULL
)	NULL
that	NULL
we	NULL
previously	NULL
mapped	NULL
by	NULL
deletion	NULL
analysis	NULL
(	NULL
20	NULL
)	NULL
.	NULL

In	NULL
its	NULL
turn	NULL
,	NULL
this	NULL
minimal	NULL
DNA-binding	NULL
domain	NULL
of	NULL
NFAT1	NULL
corresponds	NULL
exactly	NULL
to	NULL
the	NULL
N-terminal	NULL
specificity	NULL
subdomain	NULL
of	NULL
the	NULL
p50	NULL
NF-kB	NULL
DNA-binding	NULL
domain	NULL
(	NULL
13	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
conserved	NULL
DNA	NULL
recognition	NULL
loop	NULL
(	NULL
RFRYxCEG	NULL
)	NULL
near	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
,	NULL
which	NULL
makes	NULL
multiple	NULL
DNA	NULL
contacts	NULL
in	NULL
p50	NULL
NF-kB	NULL
(	NULL
13	NULL
,	NULL
37	NULL
)	NULL
,	NULL
corresponds	NULL
to	NULL
a	NULL
completely	NULL
conserved	NULL
sequence	NULL
(	NULL
RAHYETEG	NULL
)	NULL
of	NULL
NFAT	NULL
proteins	NULL
that	NULL
we	NULL
have	NULL
shown	NULL
by	NULL
mutational	NULL
analysis	NULL
is	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
by	NULL
NFAT1	NULL
(	NULL
20	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
proteins	NULL
,	NULL
recombinant	NULL
fragments	NULL
containing	NULL
the	NULL
DNA-binding	NULL
domains	NULL
of	NULL
all	NULL
four	NULL
NFAT	NULL
family	NULL
proteins	NULL
bind	NULL
with	NULL
similar	NULL
affinities	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
NFAT	NULL
site	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
the	NULL
highly	NULL
conserved	NULL
minimal	NULL
DNA-binding	NULL
domain	NULL
is	NULL
sufficient	NULL
for	NULL
this	NULL
cooperative	NULL
interaction	NULL
(	NULL
20	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
,	NULL
there	NULL
appear	NULL
to	NULL
be	NULL
differences	NULL
in	NULL
the	NULL
binding-site	NULL
selectivity	NULL
of	NULL
the	NULL
four	NULL
NFAT	NULL
proteins	NULL
for	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoter	NULL
NFAT	NULL
sites	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
differences	NULL
in	NULL
binding-site	NULL
selectivity	NULL
suggest	NULL
that	NULL
in	NULL
vivo	NULL
,	NULL
different	NULL
NFAT	NULL
proteins	NULL
may	NULL
selectively	NULL
mediate	NULL
the	NULL
transcription	NULL
of	NULL
different	NULL
genes	NULL
.	NULL

This	NULL
question	NULL
can	NULL
not	NULL
be	NULL
readily	NULL
addressed	NULL
by	NULL
using	NULL
transient-trans-fection	NULL
systems	NULL
,	NULL
since	NULL
the	NULL
overexpressed	NULL
proteins	NULL
are	NULL
likely	NULL
to	NULL
mediate	NULL
transactivation	NULL
even	NULL
from	NULL
sites	NULL
to	NULL
which	NULL
they	NULL
bind	NULL
with	NULL
low	NULL
affinity	NULL
.	NULL

The	NULL
N	NULL
and	NULL
C	NULL
termini	NULL
of	NULL
NFAT1	NULL
show	NULL
features	NULL
of	NULL
transactivation	NULL
domains	NULL
.	NULL

Besides	NULL
the	NULL
heptad	NULL
repeat	NULL
of	NULL
leucines	NULL
mentioned	NULL
above	NULL
,	NULL
the	NULL
unique	NULL
N-terminal	NULL
region	NULL
of	NULL
NFAT1	NULL
(	NULL
D/E	NULL
P	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
contains	NULL
two	NULL
acidic	NULL
hydrophobic	NULL
patches	NULL
,	NULL
``	NULL
QDEL	NULL
DFSILFDYEY*°L	NULL
and	NULL
°YPDDVMDYG®L	NULL
,	NULL
that	NULL
resemble	NULL
those	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
transactivation	NULL
by	NULL
acidic	NULL
activation	NULL
domains	NULL
(	NULL
9	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Similar	NULL
acidic	NULL
hydrophobic	NULL
patches	NULL
are	NULL
present	NULL
in	NULL
NFAT3	NULL
(	NULL
°DEELEFKLVFGE*°E	NULL
)	NULL
and	NULL
NFAT4/	NULL
NFATx	NULL
(	NULL
°HDELDFKLVFGE*_	NULL
``	NULL
D	NULL
)	NULL
(	NULL
18	NULL
,	NULL
28	NULL
)	NULL
.	NULL

The	NULL
conserved	NULL
serine-	NULL
and	NULL
proline-rich	NULL
NHR	NULL
may	NULL
also	NULL
contain	NULL
a	NULL
transactivation	NULL
domain	NULL
;	NULL
alternatively	NULL
,	NULL
this	NULL
conserved	NULL
region	NULL
may	NULL
mediate	NULL
regulatory	NULL
interactions	NULL
or	NULL
other	NULL
functions	NULL
common	NULL
to	NULL
the	NULL
NFAT	NULL
family	NULL
.	NULL

The	NULL
C-terminal	NULL
region	NULL
(	NULL
QP	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
is	NULL
rich	NULL
in	NULL
glutamine	NULL
and	NULL
proline	NULL
and	NULL
so	NULL
may	NULL
also	NULL
constitute	NULL
a	NULL
transactivation	NULL
domain	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Transactivation	NULL
by	NULL
NFAT1	NULL
is	NULL
strongly	NULL
regulated	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
at	NULL
the	NULL
levels	NULL
of	NULL
subcellular	NULL
localization	NULL
as	NULL
well	NULL
as	NULL
cooperation	NULL
with	NULL
nuclear	NULL
transcription	NULL
factors	NULL
.	NULL

Although	NULL
recombinant	NULL
NFAT1	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
alone	NULL
,	NULL
it	NULL
mediates	NULL
only	NULL
a	NULL
low	NULL
level	NULL
of	NULL
transactivation	NULL
from	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
NFAT	NULL
site	NULL
under	NULL
these	NULL
conditions	NULL
.	NULL

Additional	NULL
stimulation	NULL
with	NULL
PMA	NULL
is	NULL
required	NULL
for	NULL
optimal	NULL
transactivation	NULL
.	NULL

The	NULL
most	NULL
likely	NULL
possibility	NULL
is	NULL
that	NULL
the	NULL
requirement	NULL
for	NULL
dual	NULL
stimulation	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
reflects	NULL
the	NULL
requirement	NULL
for	NULL
synthesis	NULL
and	NULL
posttranslational	NULL
modification	NULL
of	NULL
AP-1	NULL
proteins	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
stabilize	NULL
the	NULL
binding	NULL
of	NULL
NFAT1	NULL
and	NULL
other	NULL
NFAT	NULL
family	NULL
proteins	NULL
at	NULL
this	NULL
site	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
47	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
stimulation	NULL
with	NULL
PMA	NULL
and/or	NULL
ionomycin	NULL
is	NULL
needed	NULL
for	NULL
the	NULL
intrinsic	NULL
transactivation	NULL
functions	NULL
of	NULL
NFAT1	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
GM-CSF	NULL
promoters	NULL
,	NULL
full	NULL
activation	NULL
would	NULL
require	NULL
the	NULL
cooperation	NULL
of	NULL
NFAT1	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
as	NULL
well	NULL
as	NULL
the	NULL
additional	NULL
participation	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
for	NULL
instance	NULL
,	NULL
NF-kB	NULL
)	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
and/or	NULL
PMA	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
subcellular	NULL
localization	NULL
of	NULL
NFAT	NULL
family	NULL
proteins	NULL
is	NULL
a	NULL
question	NULL
of	NULL
considerable	NULL
interest	NULL
.	NULL

One	NULL
potential	NULL
mechanism	NULL
is	NULL
that	NULL
NFAT	NULL
family	NULL
proteins	NULL
are	NULL
actively	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
and	NULL
released	NULL
from	NULL
the	NULL
re	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

tention	NULL
mechanism	NULL
upon	NULL
stimulation	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
proteins	NULL
may	NULL
be	NULL
actively	NULL
transported	NULL
into	NULL
the	NULL
nucleus	NULL
upon	NULL
acti-vation	NULL
,	NULL
by	NULL
a	NULL
calcium-	NULL
and	NULL
calcineurin-dependent	NULL
mechanism	NULL
that	NULL
is	NULL
present	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

The	NULL
conserved	NULL
NHR	NULL
in	NULL
NFAT	NULL
family	NULL
proteins	NULL
could	NULL
function	NULL
as	NULL
a	NULL
calcineurin-sensitive	NULL
regulatory	NULL
region	NULL
to	NULL
control	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
NFAT	NULL
family	NULL
proteins	NULL
;	NULL
indeed	NULL
,	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
NFAT1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
calcineurin	NULL
directly	NULL
(	NULL
27	NULL
,	NULL
642	NULL
)	NULL
.	NULL

These	NULL
hypotheses	NULL
can	NULL
now	NULL
be	NULL
experimentally	NULL
tested	NULL
by	NULL
using	NULL
recombinant	NULL
NFAT1	NULL
proteins	NULL
that	NULL
are	NULL
correctly	NULL
regulated	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
D.	NULL
A.	NULL
Cantrell	NULL
,	NULL
M.	NULL
Tremblay	NULL
,	NULL
E.	NULL
Serfling	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
S.	NULL
L.	NULL
McKnight	NULL
,	NULL
L.	NULL
H.	NULL
Glimcher	NULL
,	NULL
P.	NULL
N.	NULL
Cockerill	NULL
,	NULL
R.	NULL
L.	NULL
Kincaid	NULL
,	NULL
and	NULL
F.	NULL
McKeon	NULL
for	NULL
reagents	NULL
.	NULL

We	NULL
thank	NULL
members	NULL
of	NULL
the	NULL
laboratory	NULL
for	NULL
helpful	NULL
discussions	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

C.L	NULL
.	NULL

was	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
Lady	NULL
Tata	NULL
Memorial	NULL
Trust	NULL
Fellowship	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
NIH	NULL
grants	NULL
CA42471	NULL
and	NULL
GM46227	NULL
(	NULL
A.R	NULL
.	NULL
)	NULL

and	NULL
grants	NULL
from	NULL
Hoffmann-LaRoche	NULL
(	NULL
A.R	NULL
.	NULL

and	NULL
P.G.H	NULL
.	NULL
)	NULL

.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Aramburu	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Azzoni	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
B.	NULL
Perussia	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
NFATp	NULL
and	NULL
NFAT	NULL
,	NULL
in	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
:	NULL
regulation	NULL
upon	NULL
CD16	NULL
ligand	NULL
binding	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:801-810	NULL
.	NULL

2	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
X.	NULL
Mao	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
B.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kovary	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NFAT-1	NULL
DNA	NULL
binding	NULL
complex	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fra-1	NULL
and	NULL
JunB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1911-1919	NULL
.	NULL

3	NULL
.	NULL

Brabletz	NULL
,	NULL
T.	NULL
,	NULL
I.	NULL
Pietrowski	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
immunosuppressives	NULL
FK506	NULL
and	NULL
cyclosporin	NULL
A	NULL
inhibit	NULL
the	NULL
generation	NULL
of	NULL
protein	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
two	NULL
purine	NULL
boxes	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
enhancer	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
:	NULL
61-67	NULL
.	NULL

3a.Carew	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Garcia-Cozar	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

4	NULL
.	NULL

Chen	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
G.	NULL
Oakley	NULL
,	NULL
J.	NULL
N.	NULL
M.	NULL
Glover	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
P.	NULL
B.	NULL
Dervan	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
G.	NULL
L	NULL
Verdine	NULL
.	NULL

1995	NULL
.	NULL

Only	NULL
one	NULL
of	NULL
the	NULL
two	NULL
DNA-bound	NULL
orientations	NULL
of	NULL
AP-1	NULL
found	NULL
in	NULL
solution	NULL
cooperates	NULL
with	NULL
NFATp	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

5:882-889	NULL
.	NULL

5	NULL
.	NULL

Choi	NULL
,	NULL
M.	NULL
S.	NULL
K.	NULL
,	NULL
R.	NULL
D.	NULL
Brines	NULL
,	NULL
M.	NULL
J.	NULL
Holman	NULL
,	NULL
and	NULL
G.	NULL
G.	NULL
B.	NULL
Klaus	NULL
.	NULL

1994	NULL
.	NULL

Induction	NULL
of	NULL
NF-AT	NULL
in	NULL
normal	NULL
B	NULL
lymphocytes	NULL
by	NULL
anti-immunoglobulin	NULL
or	NULL
CD40	NULL
ligand	NULL
in	NULL
conjunction	NULL
with	NULL
IL-4	NULL
.	NULL

Immunity	NULL
1:179-187	NULL
.	NULL

6	NULL
.	NULL

Chuypilo	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Schomberg	NULL
,	NULL
R.	NULL
Gerwig	NULL
,	NULL
A.	NULL
Heinfling	NULL
,	NULL
R.	NULL
Reeves	NULL
,	NULL
F.	NULL
Grummt	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1993	NULL
.	NULL

Multiple	NULL
closely-linked	NULL
NFAT/octamer	NULL
and	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
are	NULL
part	NULL
of	NULL
the	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5694-5704	NULL
.	NULL

7	NULL
.	NULL

Clipstone	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
calcineurin	NULL
as	NULL
a	NULL
key	NULL
signaling	NULL
enzyme	NULL
in	NULL
T-lymphocyte	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
357:695-697	NULL
.	NULL

8	NULL
.	NULL

Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
A.	NULL
G.	NULL
Bert	NULL
,	NULL
F.	NULL
Jenkins	NULL
,	NULL
G.	NULL
R.	NULL
Ryan	NULL
,	NULL
M.	NULL
F.	NULL
Shannon	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Vadas	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
enhancer	NULL
function	NULL
is	NULL
associated	NULL
with	NULL
cooperative	NULL
interactions	NULL
between	NULL
AP-1	NULL
and	NULL
NFATp/c	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2071-2079	NULL
.	NULL

9	NULL
.	NULL

Cress	NULL
,	NULL
W.	NULL
D.	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Triezenberg	NULL
.	NULL

1991	NULL
.	NULL

Critical	NULL
structural	NULL
elements	NULL
of	NULL
the	NULL
VP16	NULL
transcriptional	NULL
activation	NULL
domain	NULL
.	NULL

Science	NULL
251:87-90	NULL
.	NULL

10	NULL
.	NULL

Dobrzanski	NULL
,	NULL
P.	NULL
,	NULL
R.-P.	NULL
Ryseck	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1993	NULL
.	NULL

Both	NULL
N-	NULL
and	NULL
C-terminal	NULL
domains	NULL
of	NULL
ReIB	NULL
are	NULL
required	NULL
for	NULL
full	NULL
transactivation	NULL
:	NULL
role	NULL
of	NULL
the	NULL
N-terminal	NULL
leucine	NULL
zipper-like	NULL
motif	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1572-1582	NULL
.	NULL

11	NULL
.	NULL

Flanagan	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
B.	NULL
Corthésy	NULL
,	NULL
R.	NULL
J.	NULL
Bram	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
association	NULL
of	NULL
a	NULL
T-cell	NULL
transcription	NULL
factor	NULL
blocked	NULL
by	NULL
FK-506	NULL
and	NULL
cyclosporin	NULL
A	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:803-807	NULL
.	NULL

12	NULL
.	NULL

Fruman	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
S.-Y	NULL
.	NULL

Pai	NULL
,	NULL
S.	NULL
J.	NULL
Burakoff	NULL
,	NULL
and	NULL
B.	NULL
E.	NULL
Bierer	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
mutant	NULL
calcineurin	NULL
A	NULL
«	NULL
gene	NULL
expressed	NULL
by	NULL
ELA	NULL
lymphoma	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3857-3863	NULL
.	NULL

13	NULL
.	NULL

Ghosh	NULL
,	NULL
G.	NULL
,	NULL
G.	NULL
Van	NULL
Duyne	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
P.	NULL
B.	NULL
Sigler	NULL
.	NULL

1995	NULL
.	NULL

Structure	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
homodimer	NULL
bound	NULL
to	NULL
a	NULL
xB	NULL
site	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
373:303-310	NULL
.	NULL

14	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
novel	NULL
cyclosporin-sensitive	NULL
element	NULL
in	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
gene	NULL
promoter	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1365-1379	NULL
.	NULL

15	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
E.	NULL
Tsai	NULL
,	NULL
R.	NULL
Kincaid	NULL
,	NULL
P.	NULL
J.	NULL
Belshaw	NULL
,	NULL
S.	NULL
L.	NULL
Schreiber	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1994	NULL
.	NULL

Calcineurin	NULL
mediates	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
gene	NULL
induction	NULL
in	NULL
stimulated	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:763-768	NULL
.	NULL

16	NULL
.	NULL

Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1994	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
17.	NULL
transcription	NULL
factor	NULL
NFATp	NULL
in	NULL
a	NULL
neuronal	NULL
cell	NULL
line	NULL
and	NULL
in	NULL
the	NULL
murine	NULL
nervous	NULL
system	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:28181-28186	NULL
.	NULL

Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
X.	NULL
Li	NULL
,	NULL
U.	NULL
Francke	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1995	NULL
.	NULL

NFATc3	NULL
,	NULL
a	NULL
lymphoid-specific	NULL
NFAT	NULL
family	NULL
member	NULL
that	NULL
is	NULL
calcium-regulated	NULL
and	NULL
exhibits	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:19898-19907	NULL
.	NULL

17a.Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
A.	NULL
M.	NULL
Ranger	NULL
,	NULL
F.	NULL
C.	NULL
de	NULL
la	NULL
Brousse	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
and	NULL
18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1996	NULL
.	NULL

Hyperproliferation	NULL
and	NULL
dysregulation	NULL
of	NULL
IL-4	NULL
expression	NULL
in	NULL
NF-ATp-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
.	NULL

4:397-405	NULL
.	NULL

Hoey	NULL
,	NULL
T.	NULL
,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
K.	NULL
Williamson	NULL
,	NULL
and	NULL
X.	NULL
Xu	NULL
.	NULL

1995	NULL
.	NULL

Isolation	NULL
of	NULL
two	NULL
new	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
gene	NULL
family	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
NFAT	NULL
proteins	NULL
.	NULL

Immunity	NULL
2461-472	NULL
.	NULL

Hutchinson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
McCloskey	NULL
.	NULL

1995	NULL
.	NULL

FeeRI-mediated	NULL
induction	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T-cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:16333-16338	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
similar	NULL
DNA-binding	NULL
motif	NULL
in	NULL
NFAT	NULL
family	NULL
proteins	NULL
and	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:4138-4145	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
N.	NULL
Lambert	NULL
,	NULL
G.	NULL
L.	NULL
Verdine	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
and	NULL
interacts	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
365:352-355	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
V.	NULL
E.	NULL
Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
356:801-803	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
preexisting	NULL
and	NULL
nuclear	NULL
forms	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:837-848	NULL
.	NULL

Jenkins	NULL
,	NULL
F.	NULL
,	NULL
P.	NULL
N.	NULL
Cockerill	NULL
,	NULL
D.	NULL
Bohmann	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Shannon	NULL
.	NULL

1995	NULL
.	NULL

Multiple	NULL
signals	NULL
are	NULL
required	NULL
for	NULL
function	NULL
of	NULL
the	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:1240-1251	NULL
.	NULL

Kubo	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
L.	NULL
Kincaid	NULL
,	NULL
D.	NULL
R.	NULL
Webb	NULL
,	NULL
and	NULL
J.	NULL
T.	NULL
Ransom	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
Ca**/	NULL
calmodulin-activated	NULL
,	NULL
phosphoprotein	NULL
phosphatase	NULL
calcineurin	NULL
is	NULL
sufficient	NULL
for	NULL
positive	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
mouse	NULL
IL-4	NULL
gene	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

6:179-188	NULL
.	NULL

Liu	NULL
,	NULL
J	NULL
.	NULL

1993	NULL
.	NULL

FK506	NULL
and	NULL
cyclosporin	NULL
,	NULL
molecular	NULL
probes	NULL
for	NULL
studying	NULL
intracellular	NULL
signal	NULL
transduction	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
14:290-295	NULL
.	NULL

26a.Loh	NULL
,	NULL
C.	NULL
,	NULL
T.	NULL
Aramburu	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

27	NULL
.	NULL

Lob	NULL
,	NULL
C.	NULL
,	NULL
K.	NULL
T.	NULL
Y.	NULL
Shaw	NULL
,	NULL
J.	NULL
Carew	NULL
,	NULL
J.	NULL
P.	NULL
B.	NULL
Viola	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Perrino	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

Calcineurin	NULL
binds	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
and	NULL
revers-ibly	NULL
regulates	NULL
its	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:10884-10891	NULL
.	NULL

27a.Luo	NULL
,	NULL
C.	NULL
Unpublished	NULL
data	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
F.	NULL
Saito	NULL
,	NULL
C.	NULL
Hannum	NULL
,	NULL
K.-T.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1995	NULL
.	NULL

NFATx	NULL
:	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
that	NULL
is	NULL
predominantly	NULL
expressed	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2697-2706	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
A.	NULL
Tsuboi	NULL
,	NULL
J.	NULL
Shlomai	NULL
,	NULL
P.	NULL
Hung	NULL
,	NULL
K.-L.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
cis-acting	NULL
element	NULL
CLEO	NULL
mediates	NULL
induction	NULL
signals	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
recognized	NULL
by	NULL
factors	NULL
related	NULL
to	NULL
AP1	NULL
and	NULL
NFAT	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:7399-7407	NULL
.	NULL

Mattila	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
K.	NULL
S.	NULL
Ullman	NULL
,	NULL
S.	NULL
Fiering	NULL
,	NULL
E.	NULL
A.	NULL
Emmel	NULL
,	NULL
M.	NULL
McCutcheon	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
action	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
suggest	NULL
a	NULL
novel	NULL
step	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:4425-4433	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
A.	NULL
E.	NULL
Goldfeld	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
role	NULL
of	NULL
NFATp	NULL
in	NULL
cyclosporin	NULL
A-sensitive	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
gene	NULL
transcription	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:30445-30450	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
A.	NULL
M.	NULL
Ho	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
J.	NULL
Lambert	NULL
,	NULL
N.	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
G.	NULL
L.	NULL
Verdine	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
cyclosporin	NULL
A-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
262:750-754	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Perrino	NULL
,	NULL
T.	NULL
R.	NULL
Soderling	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

NF-ATp	NULL
,	NULL
a	NULL
T	NULL
lymphocyte	NULL
DNA-binding	NULL
protein	NULL
that	NULL
is	NULL
a	NULL
target	NULL
for	NULL
calcineurin	NULL
and	NULL
immunosuppressive	NULL
drugs	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:3747-3752	NULL
.	NULL

Milan	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Griffith	NULL
,	NULL
M.	NULL
Su	NULL
,	NULL
E.	NULL
R.	NULL
Price	NULL
,	NULL
and	NULL
F.	NULL
McKeon	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
latch	NULL
region	NULL
of	NULL
calcineurin	NULL
B	NULL
is	NULL
involved	NULL
in	NULL
both	NULL
immunosuppressant-immunophi-lin	NULL
complex	NULL
docking	NULL
and	NULL
phosphatase	NULL
activation	NULL
.	NULL

Cell	NULL
79:437-447	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Science	NULL
245:371-378	NULL
.	NULL

Mizushima	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
S.	NULL
Nagata	NULL
.	NULL

1990.	NULL
pEF-BOS	NULL
,	NULL
a	NULL
powerful	NULL
mammalian	NULL
expression	NULL
vector	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:5322	NULL
.	NULL

Muller	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
F.	NULL
A.	NULL
Rey	NULL
,	NULL
M.	NULL
Sodeoka	NULL
,	NULL
G.	NULL
L.	NULL
Verdine	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Harrison	NULL
.	NULL

1995	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
homodimer	NULL
bound	NULL
to	NULL
DNA	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
373:311-317	NULL
.	NULL

Nalefski	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
K.	NULL
T.	NULL
Y.	NULL
Shaw	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

An	NULL
ion	NULL
pair	NULL
in	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
heterodimers	NULL
critical	NULL
for	NULL
surface	NULL
expression	NULL
and	NULL
peptide	NULL
presentation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:22351-22360	NULL
.	NULL

Nardone	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1994	NULL
.	NULL

Delineation	NULL
of	NULL
a	NULL
region	NULL
in	NULL
the	NULL
B2	NULL
bradykinin	NULL
receptor	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
high-affinity	NULL
agonist	NULL
binding	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:4417-4421	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
1994	NULL
.	NULL

NF-AT-AP-1	NULL
and	NULL
Rel-bZIP	NULL
:	NULL
hybrid	NULL
vigor	NULL
and	NULL
binding	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

REGULATION	NULL
OF	NULL
RECOMBINANT	NULL
NFAT1I	NULL
3965	NULL
under	NULL
the	NULL
influence	NULL
.	NULL

Cell	NULL
77:795-798	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
369:497-502	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
K.	NULL
S.	NULL
Ullman	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
the	NULL
lymphoid-specific	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:2917-2923	NULL
.	NULL

O'Keefe	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
J.	NULL
L	NULL
Tamura	NULL
,	NULL
R.	NULL
L.	NULL
Kincaid	NULL
,	NULL
M.	NULL
J.	NULL
Tocci	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
O'Neill	NULL
.	NULL

1992	NULL
.	NULL

FK-506-	NULL
and	NULL
CsA-sensitive	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
by	NULL
calcineurin	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
357:692-694	NULL
.	NULL

Park	NULL
,	NULL
J.	NULL
,	NULL
N.	NULL
R.	NULL
Yaseen	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
S.	NULL
Sharma	NULL
.	NULL

1995	NULL
.	NULL

Phos-phorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFATp	NULL
inhibits	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
cyclosporin	NULL
A-treated	NULL
human	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
20653-20659	NULL
.	NULL

Perrino	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
L.	NULL
Y.	NULL
Ng	NULL
,	NULL
and	NULL
T.	NULL
R.	NULL
Soderling	NULL
.	NULL

1995	NULL
.	NULL

Calcium	NULL
regulation	NULL
of	NULL
calcineurin	NULL
phosphatase	NULL
activity	NULL
by	NULL
its	NULL
B	NULL
subunit	NULL
and	NULL
calmodulin	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:340-346	NULL
.	NULL

Prieschl	NULL
,	NULL
E.	NULL
E.	NULL
,	NULL
V.	NULL
Gouilleux-Gruart	NULL
,	NULL
C.	NULL
Walker	NULL
,	NULL
N.	NULL
E.	NULL
Harrer	NULL
,	NULL
and	NULL
T.	NULL
Baum-ruker	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cell-like	NULL
transcription	NULL
factor	NULL
in	NULL
mast	NULL
cells	NULL
is	NULL
involved	NULL
in	NULL
IL-5	NULL
gene	NULL
regulation	NULL
after	NULL
IgE	NULL
plus	NULL
antigen	NULL
stimulation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:6112-6119	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

1994	NULL
.	NULL

NF-ATp	NULL
:	NULL
a	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
the	NULL
co-ordinate	NULL
induction	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15:274-281	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
M.	NULL
R.	NULL
Hodge	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
common	NULL
factor	NULL
regulates	NULL
both	NULL
Th1-	NULL
and	NULL
Th2-specific	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:625-633	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1995	NULL
.	NULL

Coordinate	NULL
and	NULL
cooperative	NULL
roles	NULL
for	NULL
NFAT	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
.	NULL

Immunity	NULL
2473-483	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
R.	NULL
Narayanan	NULL
,	NULL
J.	NULL
F.	NULL
Klement	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1992	NULL
.	NULL

Functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-xB	NULL
p65	NULL
transcriptional	NULL
activator	NULL
and	NULL
an	NULL
alternatively	NULL
spliced	NULL
derivative	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:444-454	NULL
.	NULL

Ruff	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
L.	NULL
Leach	NULL
.	NULL

1995	NULL
.	NULL

Direct	NULL
demonstration	NULL
of	NULL
NFATp	NULL
dephosphorylation	NULL
and	NULL
nuclear	NULL
localization	NULL
in	NULL
activated	NULL
HT-2	NULL
cells	NULL
using	NULL
a	NULL
specific	NULL
NFATp	NULL
polyclonal	NULL
antibody	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:22602-22607	NULL
.	NULL

Sakurai	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Strominger	NULL
.	NULL

1988	NULL
.	NULL

B-cell-specific	NULL
enhancer	NULL
activity	NULL
of	NULL
conserved	NULL
upstream	NULL
elements	NULL
of	NULL
the	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
DQB	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:6909-6913	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
M.	NULL
A.	NULL
dos	NULL
Santos	NULL
Silva	NULL
,	NULL
H.	NULL
Altmann	NULL
,	NULL
M.	NULL
Czisch	NULL
,	NULL
T.	NULL
A.	NULL
Holak	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1994	NULL
.	NULL

Structural	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
C	NULL
terminus	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:25613-25620	NULL
.	NULL

Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
P.	NULL
J.	NULL
Utz	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
J.	NULL
J.	NULL
Toole	NULL
,	NULL
E.	NULL
A.	NULL
Emmel	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241:202-205	NULL
.	NULL

Shaw	NULL
,	NULL
K	NULL
.	NULL

T.-Y	NULL
.	NULL

,	NULL
A.	NULL
M.	NULL
Ho	NULL
,	NULL
A.	NULL
Raghavan	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
J	NULL
.	NULL

Park	NULL
,	NULL
S.	NULL
Sharma	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1995	NULL
.	NULL

Immunosuppressive	NULL
drugs	NULL
prevent	NULL
a	NULL
rapid	NULL
dephosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
in	NULL
stimulated	NULL
immune	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:11205-11209	NULL
.	NULL

Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
C.	NULL
A.	NULL
Norris	NULL
,	NULL
M.	NULL
Kamoun	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Kant	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1986	NULL
.	NULL

Promoter	NULL
region	NULL
of	NULL
interleukin-2	NULL
gene	NULL
undergoes	NULL
chromatin	NULL
structure	NULL
changes	NULL
and	NULL
confers	NULL
inducibil-ity	NULL
on	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
during	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:3042-3049	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
H.	NULL
J.	NULL
Rahmsdorf	NULL
,	NULL
A.	NULL
Steffen	NULL
,	NULL
M.	NULL
Litfin	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1989	NULL
.	NULL

UV-induced	NULL
DNA	NULL
damage	NULL
is	NULL
an	NULL
intermediate	NULL
step	NULL
in	NULL
UV-induced	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
collagenase	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
metallo-thionein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

95169-5181	NULL
.	NULL

Szabo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
J.	NULL
S.	NULL
Gold	NULL
,	NULL
T.	NULL
L.	NULL
Murphy	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
controlling	NULL
interleukin-4	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
roles	NULL
for	NULL
NF-Y	NULL
and	NULL
NF-ATc	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4793-4805	NULL
.	NULL

Tillman	NULL
»	NULL
,	NULL
U.	NULL
,	NULL
J.	NULL
Wagner	NULL
,	NULL
D.	NULL
Boerboom	NULL
,	NULL
H.	NULL
Westphal	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Tremblay	NULL
.	NULL

1994	NULL
.	NULL

Nuclear	NULL
localization	NULL
and	NULL
cell	NULL
cycle	NULL
regulation	NULL
of	NULL
a	NULL
murine	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:3030-3040	NULL
.	NULL

Tocci	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
D.	NULL
A.	NULL
Matkovich	NULL
,	NULL
K.	NULL
A.	NULL
Collier	NULL
,	NULL
P.	NULL
Kwok	NULL
,	NULL
F.	NULL
Dumont	NULL
,	NULL
S.	NULL
Lin	NULL
,	NULL
S.	NULL
Degudicibus	NULL
,	NULL
J.	NULL
J.	NULL
Siekierka	NULL
,	NULL
J.	NULL
Chin	NULL
,	NULL
and	NULL
N.	NULL
Hutchinson	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
immu-nosuppressant	NULL
FK506	NULL
selectively	NULL
inhibits	NULL
expression	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:718-726	NULL
.	NULL

Todd	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Lederer	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
A.	NULL
H.	NULL
Lichtman	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
interleukin	NULL
4	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
multiple	NULL
promoter	NULL
elements	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:1663-1674	NULL
.	NULL

Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
E.	NULL
S.	NULL
Masuda	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
K.-I	NULL
.	NULL

Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1994	NULL
.	NULL

Calcineurin	NULL
potentiates	NULL
activation	NULL
of	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
involvement	NULL
of	NULL
the	NULL
conserved	NULL
lym-phokine	NULL
element	NULL
0	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

5:119-128	NULL
.	NULL

Venkataraman	NULL
,	NULL
L.	NULL
,	NULL
D.	NULL
A.	NULL
Francis	NULL
,	NULL
Z.	NULL
Wang	NULL
,	NULL
J.	NULL
Liu	NULL
,	NULL
T.	NULL
L.	NULL
Rothstein	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1994	NULL
.	NULL

Cyclosporin	NULL
A-sensitive	NULL
induction	NULL
of	NULL
NF-AT	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

Immunity	NULL
1:189-196	NULL
.	NULL

Wang	NULL
,	NULL
D.	NULL
Z.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
cyclosporin-sensitive	NULL
transcription	NULL
factor	NULL
NFATp	NULL
is	NULL
expressed	NULL
in	NULL
several	NULL
classes	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
3966	NULL
LUO	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

immune	NULL
system	NULL
.	NULL

Ann	NULL
.	NULL

N.	NULL
Y.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

766:182-194	NULL
.	NULL

66	NULL
.	NULL

Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
B.	NULL
Viola	NULL
,	NULL
K.	NULL
T.	NULL
Y.	NULL
Shaw	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
J.	NULL
D.	NULL
Wallace	NULL
,	NULL
P.	NULL
T.	NULL
64a.Wesselborg	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
A.	NULL
Fruman	NULL
,	NULL
J.	NULL
K.	NULL
Sagoo	NULL
,	NULL
B.	NULL
E.	NULL
Bierer	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Burakoff	NULL
.	NULL

Bozza	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
unexpected	NULL
phenotype	NULL
of	NULL
enhanced	NULL
1996	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
calcineurin	NULL
and	NULL
nuclear	NULL
immune	NULL
responses	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
.	NULL

Science	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFATp	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:1274-1277	NULL
.	NULL

272:892-895	NULL
.	NULL

65	NULL
.	NULL

Woodrow	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
A.	NULL
Clipstone	NULL
,	NULL
and	NULL
D.	NULL
Cantrell	NULL
.	NULL

1993.	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
and	NULL
calcineurin	NULL
67	NULL
.	NULL

Yaseen	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
A.	NULL
L.	NULL
Maizel	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
S.	NULL
Sharma	NULL
.	NULL

1993	NULL
.	NULL

Comparative	NULL
synergize	NULL
to	NULL
regulate	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
:	NULL
analysis	NULL
of	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
complex	NULL
in	NULL
human	NULL
T	NULL
1517-1522.	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:14285-14293	NULL
.	NULL

